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Apatite nanoparticles are the main inorganic component of human hard tissues, and 
have been used in repair of bone defects or scaffolds for bone tissue engineering. It has a 
stable hexagonal crystal structure, which could be employed as a host matrix for 
lanthanides doping to prepare both downconversion and upconversion fluorescent 
nanoparticles. In the thesis, lanthanide doped apatite nanoparticles have been prepared by 
hydrothermal synthesis, and their structure, luminescence properties, cell proliferation, and 
their fluorescent tracking in vitro and in vivo have been investigated. The novel apatite 
fluorescence probe is expected to overcome the shortcomings such as instability and 
photobleaching of organic fluorophores, and the potential toxicity from quantum dots.  
The terbium (Tb) doped fluorapatite (FA:Tb) and hydroxyapatite (HA:Tb) 
nanocrystals with a uniform slender morphology exhibit bright green fluorescence, good 
cytocompatibility and excellent cell imaging capacity, providing feasibility for imaging 
and tracking of cells with multilineage differentiation. The Yb3+/Ho3+ co-doped apatite 
nanoparticles are firstly prepared with both green and red upconversion emissions under 
980 nm near-infrared excitation. The 543 and 654 nm upconversion emission signals could 




5I8 transitions of holmium after energy 
transfer from ytterbium under 980 nm excitation. The FA:Yb3+/Ho3+ results in a superior 
green luminescence, while HA:Yb3+/Ho3+ dominates in red emission. The difference in 
green and red emission behavior between FA:Yb3+/Ho3+ and HA:Yb3+/Ho3+ is dependent 
on their lattice structure and composition. Several reasonable lanthanide embedding lattice 
models along the fluorine channel or hydroxyl channel of FA or HA crystal cell are 
proposed, and reveal a necessity for coexistent substitution mechanism.  
 
xvi 
The upconversion apatite nanoparticles are used for the first time to clearly distinguish 
the implanted material from bone tissue, and to track their respective distribution in vivo. 
The superposition of fluorescent images including the upconversion apatite and the 
Masson’s stained bone tissue indicates that new bone tissue could grow into the interval 
space between the apatite particles and fully integrate with these particles. The 
upconversion material and fluorescence superposition method provide a novel strategy for 
long-term discriminable fluorescence tracking of implanted materials and scaffolds. 
These fluorescent apatite nanoparticles can not only form bonding with bone tissue, 
but also provide stable and clear fluorescence, which can be utilized for long-term 
bioimaging, distinguishing scaffold from newly formed bone tissue or identifying the 
interface between implanted material and bone tissue, and tracking the distribution of 
degraded scaffold fragments in vivo. Both the lanthanide doped apatite nanoparticles and 






CHAPTER 1 INTRODUCTION 
Overview aims 
Bone tissue engineering have been the hot topics of biomaterial research in recent 
years, in which hydroxyapatite usually acts as the bioactive component, mainly due to the 
fact that the inorganic constituent of human calcified tissues is from apatite crystals.[1, 2] 
Synthetic apatites, including hydroxyapatite [Ca10(PO4)6(OH)2, HA] and fluorapatite 
[Ca10(PO4)6F2, FA], have been widely used as defect fillers of bones and teeth or 
component of tissue engineering scaffolds based on their good biocompatibility and bone-
bonding capacity.[3, 4] We already know that the bone mesenchymal stem cells (BMSCs) 
can differentiate into osteoblasts or chondrogenic cells and play an important role during 
osteogenesis. However, we lack a tracer method to see how BMSCs can differentiate into 
osteoblasts or chondrogenic cells. We also know that, the implanted apatite-based 
biomaterials can bond with bone tissue or undergo degradation while the formation of new 
bone, but how the apatite biomaterials are involved in bone regeneration and what happens 
during the process are still unclear.  
The specific aims of this research is to design and prepare new fluorescent probes 
based on rare earth doped apatite nanoparticles to track the differentiation and osteogenic 
processes of cells and bony tissues, including selecting right doping matrix and dopants, 
evaluating the system and tracking the cells and implanted biomaterials. 
Background  
Bone tissue engineering technology has significantly evolved with nanoscale 
strategies for materials construction and synergetic strategies for combining with cells and 
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molecules.[5, 6] Thus tissue engineers need versatile imaging tools to assess the construction, 
including morphology and interactions with cells and tissue. Numerous studies still use 
conventional methods, such as Hematoxylin and eosin (H&E) or Masson’s staining to 
distinguish the newly formed bone tissue on the histological section of scaffolds.[3] 
However, it is invasive and provides limited information especially in the case of in vivo 
approaches;[7] it is difficult to clearly distinguish the scaffold material and material-tissue 
interface on these histological sections. Previous studies have used environmental scanning 
electron microscopy (ESEM) to distinguish the newly mineralized bone from the biphasic 
calcium phosphate (BCP) scaffold during osteogenesis based on the image grey values.[8] 
However, this method only provides a limited field of view, hardly allowing a full 
correlative investigation on changes in the ultrastructure over a macroscopic sample. 
Small-angle X-ray scattering (SAXS) remains constrained to isotropically oriented 
ultrastructures.[9] Therefore, novel methods are needed to distinguish the scaffold from the 
newly formed bone tissue. 
Figure 1-1 briefly presents common imaging methods with their own range of imaging 
depth and the information they can provide，including magnetic resonance imaging (MRI), 
X-ray computed tomography (CT), positron emission tomography (PET), single photon 
emission computed tomography (SPECT), ultrasound and photoacoustic imaging, optical 
coherence tomography (OCT), optical imaging including upconversion (UC) luminescence 
imaging. CT, PET, and SPECT are radiodiagnostic modes, and MRI needs large 
concentration of contrast agents, though some improvement has been achieved.[10] 
Fluorescence microscopy has been the most commonly used imaging tools on in vitro 
studies, ex vivo verification including histology.[11] Owing to high sensitivity and spatial 
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resolution, fluorescence microscopy has been used to distinguish matrix and matrix-
embedded cells.[12] Two-photon fluorescence microscopy involving near-infrared 
wavelengths can increase penetration depth up to ~500 μm, and decrease photodamage and 
photobleaching because they occur only at the focus of the beam.[13, 14] Mesenchymal stem 
cells embedded in various environments[15] and scaffolds[16] can be monitored using two-
photon fluorescence microscopy. Therefore, incorporating fluorescence into scaffolds is 
one prospective strategy for achieving the purpose in this thesis. 
 
Figure 1-1 Imaging depth and information for various imaging modalities. 
 
Fluorescent probes 
Fluorescent probes play a key role in bioimaging to label the target and amplify 
fluorescent signal. The fluorophores can absorb light and jump to an excited state and then 
return to the ground state by emitting lower energy light. This energy difference between 
excitation and emission is called the Stokes shift.[17] The common fluorescent probes 
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include organic dyes, quantum dots, and rare-earth dopants. As microscopes have become 
more advanced, traditional organic fluorophores such as green fluorescent protein (GFP) 
show disadvantages in their photobleaching, poor stability, and short lifetime.[18] Quantum 
dots (QDs) are fluorescent semiconductor nanoparticles with spherical shape and < 10 nm 
in diameter.[19] The emission spectra of QDs can be tuned by changing their size.[20] And 
their advantage over organic fluorophores is that single excitation wavelength can be used 
to excite QDs with various colors. But they have shortcomings in toxicity, photo-blinking, 
susceptible to photooxidation and short circulation half times, which limit their biological 
applications.[21] Recently, lanthanide doped downconversion (DC) and upconversion (UC) 
particles have drawn great attention due to their photostability, high contrast and low toxicity.[22, 23]  
Materials which can emit fluorescence when excited by UV or blue light are called 
downconversion (DC) materials.[24] DC is a non-linear optical phenomenon in which a high 
energy photon is absorbed followed by emitting two low energy photons. In addition to 
downconversion nanoparticles requiring an ultraviolet or blue excitation, the upconversion 
nanoparticles (UCNPs) with excitation of near-infrared laser show deep penetration in tissues 
(Figure 1-2A), multiplexing ability, and avoidance of tissue auto-fluorescence and possible fatal 
photodamage to cells.[25-28] Cells and tissues may have many fluorescent components of their 
own, resulting in unwanted background fluorescence known as auto-fluorescence when 
excited by UV or blue light. The upconversion process was first proposed in 1959,[29] which 
involves anti-Stokes shifts by upconverting low energy photons into high energy photons. When 
excited by a 980 nm NIR laser, the sensitizers (Yb3+ ions) can transfer energy to the nearby 
activators (Ho3+, Er3+, and Tm3+ ions) to emit short-wavelength luminescence (Figure 1-2B).[30] 
UCNPs have also advantages as photostable, sharp visible emission bandwidth,[23, 31]  and are 
better for in vivo tracking studies over downconversion materials. The UCNPs can be ideal 
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fluorescent probes for a variety of biological applications, e.g. detection,[32, 33] imaging,[34, 35] cell 
tracking,[36] and therapy.[37] Most UCNPs have multi-photon (bicolor) emissions which paves 
the way to increase microscopy resolution.[38] The quantum yields (QYs) of UCNPs are 
very low, which hardly exceed 1% in water, and bulk materials or dried particles have 
higher QYs. The poor QYs are still acceptable for UNCPs due to a black background and 
avoidance of auto-luminescence.[39] Popular host matrixes that can house rare-earth ions to 
trigger upconverting fluorescence comprise NaYF4,
[34] NaGdF4,
[40] and LaPO4,
[41] whereas their 
composition is not similar to biological apatite, which may block further in vivo biomedical 
applications. The limitations and merits of various fluorescent probes are summarized in 
Table 1-1. 
 
Figure 1-2 (A) Schematic representation of tissue penetration depth of various wavelength 
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Selecting right doping matrix and dopants 
Apatite crystal structure as the doping matrix 
It is highly desirable that the apatite can be replaced by native tissue (bone or dentin); 
the implant dissolves gradually as the new tissue forms. Nanoparticles with unique size 
less than ~100 nm (at least one dimension) provide a wide range of biomedical applications 
such as cell imaging, as cells are much larger (average diameter ~ 10μm) in comparison.[19] 
Considering size effect, the nanoapatite are more soluble and osteogenic.[42] Despite their 
same composition to bulk materials, nanoparticles represent new properties, interactions 
with biological components, and distribution within the body. HA and FA have a similar 
crystal structure (hexagonal system, space group, P63/m) firstly solved in 1964.
[43] Figure 
1-3A shows that the unit cell of HA [Ca10(PO4)6(OH)2] consists of ten Ca
2+ ions, six PO4
3- 
groups, and two OH- groups closely packed together with the lowest possible energy. The 
network of PO4
3- groups provides the skeletal framework that gives the apatite structure its 
stability. The two OH- groups locate in the corners of the unit cell along the c-axis at z = 
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0.25 and z = 0.75, respectively, and each OH- is surrounded by three Ca2+ ions (called Ca2+ 
triangles) (Figure 1-3B). Successive calcium triangles are rotated through 60°. Comparing 
to HA, the substitution of higher electro-negative F- for OH- may alter the lattice parameters 
and cause FA a contraction in the a-axis dimension and no significant effect on the c-axis 
dimension.[44] And a lack of local polar moment associated with Ca and F in FA may 
contribute to its chemical stability over HA.[43, 45] In dentistry the fluoride treatment of 
enamel and dentin leads to the formation of partially F substituted apatite with more 
resistant to acid dissolution.[46] Fluoride therapy has been used to increase bone density for 




Defects and impurities in apatite structure can be identified as either substitutional or 
extraneous crystalline phases, which can be detected by X-ray diffraction (XRD) and 
infrared spectroscopy (FT-IR). As shown in the XRD powder patterns (Figure 1-4),[1] bone 
has broader peaks than highly crystalline HA, while similar to the wet-synthesized apatite. 
The broadening of the peaks may be caused by the imperfections in the crystal lattice and 
the small crystal size. The Ca/P molar ratio distinct from the predicted 1.67 by chemical 
analysis has been confirmed the lack of stoichiometry of bone apatite. 
Substitution of foreign ions and vacancies into the apatite crystal structure are 
common and affect lattice parameters (a- and c- axis dimensions), morphology, and thermal 
Figure 1-3 Schematic of the unit cell of HA (A), the two calcium triangles and OH channel 
in the center (B). Calculated simulation with Material Studio software. 
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stability.[48] The flexibility of the apatite structure allows a great variability of the 
composition as may be seen from that CO3
2- can substitute for PO4
3- or OH-, F- and Cl- can 
substitute OH-, and Ca2+ sites are easy to be substituted by many cations for various 
purposes. The substitution of Si4+,[49] Sr2+,[50] CO3
2- [51] can increase osteogenesis. The 




A wide variety of methods have been investigated to produce apatite, including solid-
state reactions, hydrolysis and subsequent sintering at high temperatures, among which 
aqueous precipitation is the most popular route since 1960s.[1] Aqueous precipitation is 
mainly based on two synthetical routes: a reaction between a calcium salt (e.g., Ca(NO3)2) 
and an alkaline phosphate (e.g., Na3PO4),
[53, 54] or a reaction between calcium hydroxide 
Figure 1-4 X-ray diffraction powder patterns for (top to bottom) - poorly crystalline HA 
(HAp), bovine cortical bone (Bone), HA ceramic, and highly crystalline HA (HAx). 
Adapted with permission from Hench.[1] Copyright (2013) Elsevier. 
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and phosphoric acid.[55] Uniform apatite crystals can be prepared using hydrothermal 
methods.[56] In order to overcome uncontrolled agglomerates of nanoparticles caused by 
the high surface area, additives are involved to interact with the apatite surface, including 
polyacrylic acid (PAA), EDTA, sodium dodecyl sulfate (SDS), gelatin, collagen, and 
various organic acids.[57, 58] Beside size, apatite can be prepared with various shapes, such 
as spheres,[59] yolk–shell,[60] plates, rods, tubes.[61] 
In recent years, some rare-earth doped materials are found to emit fluorescence when 
excited by ultraviolet (UV) or near-infrared (NIR) light.[62-64] The apatite crystal structure 
could be employed as a host matrix for lattice-substitution of rare-earth ions, to prepare 
both downconversion and upconversion fluorescent nanoparticles. The hexagonal structure 
of apatite crystals may be dominant in rare-earth doping and keeping thermal and 
fluorescent stability.[65, 66] The doping of Ln has a destabilizing effect, which increase with 
dopant concentration.[67] The trivalent lanthanide ions are sensitive to the chemical 
environments involved.[18] The lanthanide fluorescence has advantage over organic 
luminophores subject to photobleaching,[68] or semiconductor quantum dots (QDs) with 
potential toxicity of Cd/Se and short circulation half-time.[69]  
Lanthanide ions as the fluorescent dopants for apatite  
Lanthanide is any of a series of chemically similar metallic elements with atomic numbers 
ranging from 57 (lanthanum) through 71 (lutetium). The lanthanides, together with yttrium and 
scandium, constitute the rare-earth elements (Figure 1-5). The emission spectra range from UV, 
visible and near-infrared (NIR) regions (Figure 1-2A). The optical properties of Ln3+ ions are 
attributed to their electronic energy levels, generated by the electronic configurations [Xe]4fn (n = 




Figure 1-5 Periodic table showing the distribution of lanthanide elements. 
 
Herein we selected apatite matrix that can not only house lanthanide ions but also possess 
good biocompatibility, and facilitate tissue-material interactions. The lanthanide ions have 
analogical radius as Ca2+ ions and high affinity to PO43- ions,
[65, 70] which can ensure the success of 
rare-earth doping.  
Though a few kinds of UCNPs have appeared these years,[35, 71, 72] there are few reports on 
upconversion luminescence based on FA or HA matrix. Combination of the upconversion 
fluorescent property of Yb/Ho ions, the excellent bone-bonding capacity and typical crystal 
structure of apatite will afford us to design a promising upconversion biomaterial for biomedical 
applications. Moreover, near infrared (NIR) light can penetrate deeper in the body and shows less 
damage to cells than UV and blue light (Figure 1-2A). Upconversion particles as biomarkers are 
attractive for use in design of new probes and bioimaging applications. Work has been performed 
on multicolor tuning of upconversion probes and minimizing heating effect of excitation.[35, 73] 
Additional studies have shown applications in long-term real-time cell imaging[68] and in small-
animal imaging.[74] However, there have so far been no reports on the potential of upconversion 




The goal of this thesis is to create new biocompatible fluorescent nano-apatites which 
can not only form bonding with bone tissue, but also provide stable and clear fluorescence 
imaging. The novel fluorescence probes are expected to overcome the shortcomings such 
as instability and photobleaching of organic fluorophores, and the potential toxicity from 
QDs. Several lanthanides doped apatite nanocrystals are designed for downconversion and 
upconversion luminescence, and prepared by hydrothermal synthesis Their crystal 
structure, luminescence properties, cell proliferation and fluorescent imaging are 
investigated to validate the following unsolved scientific problems: 
1) Although the fluorescent properties of some rare-earth doped downconversion 
materials have been studied, the effects of the lanthanide ions on crystal 
structure, lattice occupation, cell proliferation and bioimaging are not 
investigated in detail, and not compared between HA and FA nanocrystals.  
2) Despite a few kinds of upconversion particles have appeared these years, there 
are few reports on upconversion luminescence based on the FA or HA matrix. 
Combination of the upconversion fluorescent property of Yb/Ho ions with the 
excellent bone-bonding capacity of apatite will afford us to design a promising 
upconversion material for biomedical applications. 
3) At present, the upconversion particles as biomarkers have exhibited steady 
developments in design of new probes and application of cell imaging, however, 
there is no report so far on exploring the potential of upconversion materials in 





Therefore, we started to investigate in detail the effects of lanthanide ions on apatite 
crystal structure, lattice occupation, luminescence properties, cell proliferation and 
bioimaging between HA and FA nanocrystals. The lanthanide doped downconversion apatite 
nanocrystals with stable fluorescence could be fit for long-term cell imaging, and the 
upconversion nanoapatite might be an ideal option for clearly distinguishing the implanted 
material from bone tissue and showing their respective distribution. It is also useful for 
long-term in vivo tracking of implanted material or scaffold and their degraded fragments. 
In the experiments, lanthanide Tb3+, Eu3+ or Yb3+/Ho3+ doped fluorapatite (FA:Tb3+, 
FA:Eu3+, FA:Yb3+/Ho3+) and hydroxyapatite (HA:Tb3+, HA:Eu3+, HA:Yb3+/Ho3+) 
nanoparticles with varying dopant concentration were prepared by hydrothermal synthesis. 
Their physico-chemical properties were characterized by XRD, FT-IR, SEM, TEM, EDS 
and ICP-OES, the upconversion emissions were detected by fluorescence spectrometry. 
Cell proliferation was evaluated via MTT assay, and animal experiments were performed 
by using femoral bone defect model of rabbits. The cells penetrated by the lanthanide doped 
nanoparticles, and the histological sections of the harvested in vivo samples treated by 




CHAPTER 2 COMPARATIVE INVESTIGATION ON CRYSTAL 
STRUCTURE AND CELL BEHAVIOR OF RARE-EARTH DOPED 
DOWNCONVERSION FLUORESCENT APATITE NANOCRYSTALS 
Introduction 
The mineral phase of human calcified tissues is mainly composed of nano apatite 
crystals.[2] Synthetic apatite, including hydroxyapatite (Ca10(PO4)6(OH)2, HA) and 
fluorapatite (Ca10(PO4)6F2, FA), has a similar hexagonal structure to biological apatite. The 
flexibility of the apatite structure allows a great variability of the composition as may be 
seen from that the Ca2+ sites are easy to be substituted by many other ions, such as Mg2+, 
Sr2+, Na+ or Al3+ etc.[75-77] Due to the similarity of composition or structure, both HA and 
FA possess good biocompatibility and have been widely used as defect fillers of bones and 
teeth.[3, 4] In recent years, some rare-earth doped materials are found to emit fluorescence 
when excited by UV or blue light.[62, 63] The hexagonal structure of apatite crystals may be 
dominant in rare-earth doping and keeping thermal and fluorescent stability.[65, 66] 
The trivalent lanthanide ions are sensitive to the chemical environments involved.[18] 
The lanthanide fluorescence has advantage over organic luminophores subject to 
photobleaching,[68] or semiconductor quantum dots with potential toxicity of Cd/Se and 
short circulation half-time.[69] Terbium (Tb) doped materials have been reported to generate 
green fluorescence.[78, 79] Although the preparation method and fluorescent properties of 
these Tb-doped materials were studied broadly, the effects of Tb3+ ions on crystal structure, 
lattice occupation and cell proliferation are not investigated in detail, and not compared 
between HA and FA nanocrystals. In order to reasonably express the incorporation 
mechanism of Tb3+ ions into the apatite lattice and explore the effect of Tb3+ doping on 
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crystal structure and cell proliferation, a doping molar ratio, 1.7/8.3, of terbium relative to 
calcium in a unit cell was chosen in this experiment. 
Materials and methods  
Materials 
Ca(NO3)2·4H2O, Tb(NO3)3·6H2O, Eu(NO3)3·6H2O, Na3PO4·12H2O, NaF, 
octadecylamine, oleic acid, ethanol, and cyclohexane in AR grade were obtained from 
Beijing Chemical Reagents Company, China. Dextran 20,000 in AR grade was purchased 
from Sinopharm Chemical Reagent Company, China. Other chemical agents obtained from 
commercial routes were of analytical grade and used without further purification. 
Preparation of apatite nanocrystals doped with Tb3+ 
Octadecylamine (0.5 g) was dissolved in oleic acid (4 mL) and ethanol (16 mL) under 
magnetic stirring in a Teflon-lined autoclave (50 mL). Then aqueous solution of Ca(NO3)2 
(0.28 M, 7 mL), Tb(NO3)3 (0.05-0.20M, 2 mL), and Na3PO4 (0.20 M, 7 mL) was added. 
For FA:Tb3+, additional NaF (0.24 M, 2 mL) was added. Afterwards, the mixture was 
agitated for 10 min, and hydrothermally treated at 160 °C for 16 h. After cooling to room 
temperature naturally, the white precipitate collected by centrifugation (10 min at 2700 × 
g) was fully washed and freezing-dried. 
Preparation of apatite nanocrystals doped with Eu3+ 
Octadecylamine (0.5 g) was dissolved in oleic acid (4 mL) and ethanol (16 mL) under 
magnetic stirring in a Teflon-lined autoclave (50 mL). Then aqueous solution of Ca(NO3)2 
(0.28 M, 7 mL), Eu(NO3)3 (0.05-0.20M, 2 mL), and Na3PO4 (0.20 M, 7 mL) was added. 
For FA:Eu3+, additional NaF (0.24 M, 2 mL) was added. Afterwards, the mixture was 
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agitated for 10 min, and hydrothermally treated at 160 °C for 16 h. After cooling to room 
temperature naturally, the white precipitate collected by centrifugation (10 min at 2700 × 
g) was fully washed and freezing-dried. 
Characterization 
X-ray diffraction (XRD) powder patterns were acquired with a Philips X' Pert Pro 
MPD equipment in the 2θ range from 20° to 60° with Cu Kα radiation (λ = 1.5406 Å). 
Transmission Electron Microscope (TEM) images of the nanocrystals were collected on an 
FEI TecnaiG2 T20 instrument at 200KV. The binding energy data were measured by XPS 
spectrum, AXIS Ultra DLD, Kratos, UK. The Tb/Ca molar ratio was tested by ICP-OES, 
Teledyne Leeman, USA. The photoluminescence was recorded by the Hitachi F-7000 
fluorescence spectrophotometer. 
Cytotoxicity assay 
BMSCs were seeded in a 96-well flat-bottomed microplate at a density of 20, 000 cells 
per well, and cultured in 5% CO2 at 37 °C for 48 h. Then FA:Tb
3+, FA:Eu3+, HA:Tb3+, and 
HA:Eu3+ nanocrystals with a concentration of 100 μg mL-1 were added to the medium. 
After incubation for 1, 4, 7, and 11 days at 37 °C, these nanocrystals were removed by 
washing with PBS for three times. 20 μL 3-[4,5-dimethylthiazol-2yl]-2,5- diphenyl-2H-
tetrazoliumbromide (MTT) solution (0.8 mg mL-1) was added into each well, and cells 
were incubated further for 4 h at 37 °C. Subsequently, the media was discarded, and the 
precipitated formazan was dissolved in dimethyl sulfoxide (DMSO, 150 μL per well), and 
optical density of the solution was recorded using a microplate reader (PerkinElmer wallac 
1420) at a wavelength of 570 nm. Results are presented as mean ± SD from triplicate wells. 
A value of p < 0.05 was considered to be statistically significant. 
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Coating of dextran on FA:Tb3+ nanocrystals 
The prepared FA:Tb3+ nanocrystals (50mg) were firstly dispersed in cyclohexane (5 
mL) and mixed with dextran solution (100 mg, 10 mL) in a 50 mL round-bottom flask. 
Then 10 mL tetrahydrofuran (THF) was added to form a turbid suspension. The mixture 
was dispersed by ultrasonication, and then stirred for 2 h at room temperature to obtain a 
homogeneous phase. Finally, they were isolated by centrifugation (3 min at 6000 rpm) and 
purified with distilled water and ethanol for three times. The product could be redispersed 
in aqueous solutions. 
Cell Imaging 
The BMSCs were seeded onto 35 mm coverglass-bottom dishes and incubated in 2 
mL of DMEM at 37 °C for 24h. The culture medium was removed and these cells were 
incubated in 2 mL DMEM containing the dextran-grafted FA:Ln3+ nanocrystals (100 μg 
mL-1) at 37 °C for 24 h. After rinsing with PBS three times, cells were fixed with 4% 
paraformaldehyde for 15 min. The fluorescence imaging was conducted under a confocal 
microscope (Leica LSM780). The green emission was collected at 488 nm. 
Statistical analysis 
The results were expressed as mean ± standard deviation (SD). Statistical comparisons 
between groups were analyzed by using one-way ANOVA test. A value of p < 0.05 was 
considered to be statistically significant. 
Results and discussion 
In order to evaluating the efficiency of the doping system, we started the preliminary 
investigation to screen the rare-earth elements and validate our hypothesis, that is, apatite 
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can be used as matrix for rare-earth doping downconversion (DC) luminescence. The 
hexagonal apatite crystal structure is selected as the doping matrix, including 
hydroxyapatite (Ca10(PO4)6(OH)2, HA), fluorapatite (Ca10(PO4)6F2, FA). Various rare-earth 
elements were tried according to literature and our research needs, we found four 
lanthanides worked for downconversion (DC) apatite system. As shown in Table 2-1, the 
emissions for Sm (samarium), Eu (europium), Tb (terbium), Dy (dysprosium) showed 
orange, red, green, and blue respectively. The luminescence color depends on their unique 
electron orbitals. Because human eyes are sensitive to red and green colors, we select Eu 
and Tb for DC dopants. The morphologies of some lanthanides co-doped FA crystals are 
shown in Figure 2-1, including nanospheres, nanorods, and nanowires. In most cases, 
apatite NPs show rod-like morphology and have been commonly used for biological 
applications. 
Table 2-1 Screening of the doping lanthanides for DC apatite system. 
 Sm3+ Eu3+ Tb3+ Dy3+ 
DC Orange Red Green Blue 
 
The crystal structure and morphology of the rare-earth doped apatite were examined 
using XRD and TEM. In Figure 2-2, the XRD patterns of both Ln3+ doped fluorapatite and 
hydroxyapatite crystals matched well with the classical hexagonal phase of apatite, FA 
(Ca10(PO4)6F2, ICDD 15-0876) or HA (Ca10(PO4)6OH2, ICDD 09-0432), respectively. The 
sharp characteristic peaks around 26°, 32°, 32.3°, 40°, 47°, 50°, and 53° corresponded to 
(002), (211), (112), (310), (222), (213), and (004) lattice planes, respectively. The Ln3+ ions 
were supposed to be incorporated into the apatite crystal lattice, and there were no impurity 
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diffraction peaks or phases in the XRD pattern. The measured lattice parameters a = b = 
0.939 nm, c = 0.688 nm for FA:Tb3+, and a = b = 0.944 nm, c = 0.688 nm for HA:Tb3+ 
were in good agreement with the data of FA (a = b = 0.937 nm, c = 0.688 nm) and HA (a = 
b = 0.942 nm, c = 0.688 nm), besides the tiny increase of the a-axis. The a-axis dimension 
of FA:Tb3+ was smaller than that of HA:Tb3+ without change of the c-axis. The hexagonal 
crystal structure of apatite has good stability, which would be helpful for stable 
fluorescence expression of the embedded rare-earth ions. 
 
Figure 2-1 The common morphologies of nanoapatite: (A) nanospheres, (B) hollow 





Figure 2-2 XRD patterns of Tb3+ or Eu3+ doped FA (A) and HA (B) nanocrystals. 
 
It could be seen from the TEM results in Figure 2-3 that both Tb3+ doped FA and HA 
crystals were in nanoscale and showed a uniform rod-like morphology (A, B). The average 
dimensions of Tb3+ doped FA and HA crystals were about 15×140 nm and 12×180 nm, 
respectively. The crystal sizes were larger than that of FA (13×75 nm) and HA (9×80 nm) 
before doping. The HRTEM images (C, D) gave the interplanar spacing of (002) lattice 
plane for FA:Tb3+ (0.345 nm) and HA:Tb3+ (0.347 nm), which was in accord with the XRD 
patterns in Figure 2-2. The EDS element mapping (E, F) demonstrated the successful 
incorporation of Tb3+ ions in the apatite crystal structure. The results indicate that the 
doping of Tb3+ ions can promote preferential growth of FA and HA crystals along the c-
axis (002) direction, and the doped nanocrystals have a typical single crystal structure with 




Figure 2-3 TEM micrographs, HRTEM images, and EDS element mapping of FA:Tb3+ (A, 
C, E) and HA:Tb3+ (B, D, F) nanocrystals. The inset in C is the FFT pattern of FA:Tb3+, 
and the inset in D is the SAED pattern of HA:Tb3+.  
 
The XPS spectra in Figure 2-4 showed that the peaks of Tb and Eu could be clearly 
observed in both apatite crystals, indicating the successful incorporation of Tb3+ and Eu3+ 
ions into the crystal lattice of FA and HA. The binding energy data of different ions for 
Tb3+ and Eu3+ doped apatite were listed in Table 2-2. After doping of Tb3+ or Eu3+ ions in 
FA and HA matrix, the binding energy of Ca, P and O showed slightly increase for FA:Ln3+ 
and slightly decrease for HA:Ln3+. This indicates that the Ln3+ ions can really enhance the 
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ion interaction in FA structure, and weaken the ion interaction in HA structure. 
 
Figure 2-4 XPS spectra of Tb3+ or Eu3+ doped apatite nanocrystals. 
 














Ca (2p) 346.8 347.1 347.1 347.0 346.8 347.1 
P (2p) 132.8 133.0 132.8 133.0 132.9 132.9 
O (1s) 530.7 530.8 530.9 531.0 530.8 531.1 
 
The emission spectra in Figure 2-5 showed luminescent peaks of apatite doped with 
various concentrations of Ln3+ ions. For Tb3+ doped apatite (A, B), when excited at 265 
nm, there were two strong green peaks at about 490 and 545 nm, which could be 
respectively ascribed to 5D4-
7F6 and 
5D4-
7F5 transitions of Tb energy levels. In FA and HA 
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matrixes, the emission intensity of 10% and 20% samples were similar, and much higher 
than the 5% sample in FA matrix. For Eu3+ doped apatite, while excited at 395 nm, they 
emit red emission (C, D) with peaks at 600 (5D0-
7F1) and 623 nm (
5D0-
7F2). And higher 
peak intensity was observed with 10% and 20% Eu3+ concentration in FA matrix. In HA 
matrix, the strongest intensity was for the 20% Eu3+ concentration. Figure 2-5E, F 
illustrated that FA:Ln3+ crystals had stronger fluorescence than that of HA:Ln3+ crystals. It 
may result from the more compact crystal structure of FA:Ln3+ crystals caused by F- ions 
and the increase of binding energy mentioned in Table 2-2. In addition, the F- ions have a 
low phonon energy which can reduce the quenching of the excited state of the rare-earth 
ions.[80, 81] The bright green and red emission can repeatedly sustain for a long time, 
implying a stable coordination between apatite crystal structure and Ln3+ ions. FA:20%Ln3+ 
crystals were used for further in vitro studies. 
Theoretically, the rare-earth doped FA:Ln3+ and HA:Ln3+ nanocrystals were 
synthesized according to the molar ratio, setting at 5, 10, and 20%, respectively. The 
analytical data by ICP-OES in Table 2-3 illustrated that the measured molar ratios of Ln/Ca 
in both FA:Ln3+ and HA:Ln3+ crystals were lower than the theoretical value; while the 
measured molar ratios of Ln/Ca in HA:Ln3+ crystals were slightly higher than that in 
FA:Ln3+. Such phenomenon should be mainly related to the difference of F- ions from OH 
groups. Both FA and HA have similar hexagonal structures, but the F- ions in FA structure 




Figure 2-5 Emission spectra of apatite nanocrystals doped with various concentrations of 








Table 2-3 Measured molar ratio of Ln3+/Ca2+ in Tb3+ or Eu3+ doped apatite nanocrystals. 
 5% 10% 20% 
FA-Tb (%) 3.436 ± 0.013 7.639 ± 0.023 16.070 ± 0.062 
HA-Tb (%) 3.732 ± 0.005 8.797 ± 0.059 20.728 ± 0.014 
FA-Eu (%) 3.042 ± 0.009 6.624 ± 0.001 13.681 ± 0.093 
HA-Eu (%) 3.012 ± 0.007 7.167 ± 0.037 14.821 ± 0.073 
 
In order to explain the substitution mechanism of Ln3+ ions in apatite crystal structure, 
the HA:Tb3+ crystals are chosen as a presentative of the Ln-doped apatite. According to the 
XRD pattern (Figure 2-2) and measured lattice parameters, the structure is retained when 
Tb3+ ion is placed for Ca2+ ion. As the measured Tb/Ca molar ratio is 1.6/8.4, a formula of 
(Ca8.4Tb1.6)(PO4)6(OH)2 can be obtained. However, to maintain the charge valence, some 
Ca2+ vacancy or substitution of O2- for –OH should be present. Thus, we propose four 
reasonable valence-balanced Tb-doped lattice models along the hydroxyl channel of HA 
hexagonal structure for HA:Tb3+ crystal (Figure 2-6). In Figure 2-6B, two Tb3+ ions replace 
two Ca2+ ions in a Ca triangle, leaving a vacancy (©) of Ca site, the molecular formula can 
be expressed as (Ca7Tb2©)(PO4)6(OH)2; In Figure 2-6C, two Tb
3+ ions and two Na+ ions 
substitute for four Ca2+ ions in two Ca triangles, forming the formula of 
(Ca6Tb2Na2)(PO4)6(OH)2. In Figure 2-6D, one Tb
3+ ion replaces one Ca2+ ion in a Ca 
triangle, and one O2- ion replaces one –OH group, leading to a cation defect compound 
(Ca9Tb)(PO4)6(OH)O. In Figure 2-6E, one Tb
3+ ion and one Na+ ion substitute for two Ca2+ 
ions in a Ca triangle, forming a formula of (Ca8TbNa)(PO4)6(OH)2. In fact, the molecular 
formula of the doped apatite is very complicated to precisely replicate, however, such 
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emulation is an effective and reasonable approach，because the total valence is balanced 
and the ionic radii of Tb3+ (92.3 pm) , Ca2+ (99 pm) and Na+(98 pm) are similar. The Tb/Ca 
molar ratios in a unit cell are about 2.2/7.8 (B), 2.5/7.5 (C), 1/9 (D) and 1.1/8.9 (E), 
respectively. The measured Tb/Ca ratio in HA:Tb3+ is 1.6/8.4, that is to say, the substitution 
of Tb3+ ions for Ca2+ ions in apatite crystals has many coexistent situations, which can be 
identical or different in each unit cell. 
 
Figure 2-6 Schematic diagram of Tb-doping lattice models along the hydroxyl channel of 
the HA hexagonal structure.  
 
To explore the potential of FA:Ln3+ crystals for future biomedical applications, we 
used hydrophilic dextran to graft the surface of these crystals for cell imaging (Figure 2-
7A). Previous studies[82] showed that apatite nanocrystals entered BMSCs via endocytosis; 
the crystals were entrapped within endosomes and then released to cytoplasm.[83, 84] 
Dextran is a cationic polymer that binds to early endosomes.[85] When grafted by dextran, 
the hydrophobic crystals become hydrophilic, which facilitates dispersity in water and 
endocytosis process. Figure 2-7B showed the FT-IR spectra of the FA:Tb3+ crystals coated 
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with or without dextran. The absorption peaks at 3458 and 1666 cm-1 attributed to typical 
stretching vibration and bending vibration of the -OH groups, and the absorption peak at 
2929 cm-1 is the typical stretching vibration of C-H in dextran. The result showed evidence 
of successful grafting of hydrophilic dextran on the crystals. The dextran-grafted FA:Tb3+  
crystals are small in size and exhibit distinct fluorescence, good dispersity in water, good 
cytocompatibility, and crystal stability, making them suitable for bioimaging investigation. 
Figure 2-7C showed that the cell proliferation of different groups with a dosage of 100 μg 
mL-1 increased continuously with time, indicating a normal growth trend and good 
cytocompatibility. The cell proliferation of reported experiments was usually evaluated 
only for 24 hours,[86, 87] which could be not sufficient to support a statement of good 
cytocompatibility. In contrast, all the samples in this experiment were carried out for a 




Figure 2-7 Schematic diagram showing dextran-coated fluorapatite nanorods doped with 
lanthanides in BMSCs (A). FT-IR spectra of dextran-coated FA:Tb3+ crystals (B). BMSCs 
proliferation after cultured with 100 μg mL-1 dosages of FA:Ln3+ nanocrystals for 1, 4, 7, 
11 days (C), error bars represent mean ± SD from triplicate experiments, p < 0.05 (* vs. 
FA, ^ vs. FA:Tb).  
 
The entering of the fluorescent FA:Tb3+ nanocrystals into the cytoplasm of cells 
(BMSCs) was demonstrated under a confocal microscope, as shown in Figure 2-8. The 
cells showed distinct and uniform green or red fluorescence, which was better than the HA 
nanoparticles surface modified with small amount of Tb3+.[88] The cell morphology and 
cytoplasm could be clearly observed or distinguished. The fluorescent images (A, D, G, J) 
of cells matched well with the light image of the cells (B, E, H, K), which gave a clear 
overlap image (C, F, I, L). Moreover, the luminescence intensity of the FA:Ln3+ 
nanocrystals could maintain repeatable even after 7 days, indicating that there was no 
apparent photobleaching occurring in the cell imaging process. This provides feasibility 
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for imaging and tracking of cells with multilineage differentiation. 
The mRNA levels of alkaline phosphatase (ALP), the alpha l chain of type I collagen 
(COL1α1), and osteonectin (ON) mRNA were analyzed via real-time PCR assay on days 
14 and 21 of differentiation. Figure 2-9 showed the mRNA change of the relative gene 
expressions. According to the real-time PCR results of ALP, COL1α1 and ON, the 
increased expression of the mRNA from the FA group clearly demonstrates that fluorapatite 


















Figure 2-8 Confocal microscope luminescent images (A, D), light images (B, E) and 
overlap images (C, F) of BMSCs treated with 100 μg mL-1 FA:Tb3+ nanocrystals. Confocal 
microscope luminescent images (G, J), light images (H, K) and overlap images (I, L) of 




Figure 2-9 Effects of the Tb–FA nanorods on the osteoblast-related gene expressions of 
BMSCs. Image analysis of (A and D) ALP, (B and E) COL-α and (C and F) gene 
expressions. The control group was treated with regular complete medium, the FA group 
was treated with 100 mg mL-1 Tb–FA with complete medium, the oil group was treated 
with the osteogenesis induced liquid, and the FA + oil group was treated with both. Adapted 
with permission from Zeng.[82] Copyright (2014) The Royal Society of Chemistry. 
 
Figure 2-10 showed the effect of the Tb–FA nanorods on the osteoblast-related protein 
expression of BMSCs. The ALP activity was detected via ALP spectrophotometry on days 
14 (A) and 21 (B) of differentiation. The following ELISA test also confirmed that rare 
earth elements do not influence fluorapatite nanorods in promoting the osteogenic 
differentiation of BMSCs. There is a synergistic effect of osteogenic differentiation 




Figure 2-10 Osteoblast-related protein expressions of Tb–FA nanorods on BMSCs. * 
indicates P < 0.05 and ** indicates P < 0.01. Adapted with permission from Zeng.[82] 
Copyright (2014) The Royal Society of Chemistry. 
 
Labelled BMSCs were seeded on the sterilized PCL scaffold that was subcutaneously 
implanted in nude mice. Samples were harvested one month (Figure 2-11A and B) and 
three months (C and D) later, respectively. Fluorescent images of the rapidly frozen 
sections were obtained via an inverted fluorescence microscope; (B) shows image staining 





Figure 2-11 Fluorescent images of rapidly frozen sections were gathered via inverted 
fluorescence microscopy. (B) Shows image staining via haematoxylin and eosin (HE) 
merged with DAPI (D). The samples were harvested after one (A and B) and three months 
(C and D) of incubation. Adapted with permission from Zeng.[82] Copyright (2014) The 
Royal Society of Chemistry.  
 
Conclusion 
The doping of Tb3+ or Eu3+ ions will influence the crystal growth and morphology of 
apatite nanocrystals, and slightly change the binding energy or ion interaction. The 
proposed lattice models express reasonably the incorporation mechanism of Tb3+ ions into 
the apatite lattice, which would be important for understanding the mechanism of 
fluorescence emission. The hydrophobic surfaces of the nanorods were converted into 
hydrophilic surfaces with the surfactant of dextran. The rod-like nanoparticles showed 
excellent biocompatibility and strong luminescence and could be utilized for labelling and 
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tracking BMSCs in vitro and in vivo by our collaborator Dr. Haifeng Zeng from Plastic 
Surgery Hospital of Peking Union Medical College and Chinese Academy of Medical 
Sciences. Labelled BMSCs were shown to reproducibly exhibit osteogenic differentiation 
potential in real-time PCR and ELISA assays. Long-term in vivo cell-tracking experiments 




CHAPTER 3 INVESTIGATION ON STRUCTURE AND 
UPCONVERSION FLUORESCENCE OF YB3+/HO3+ CO-DOPED 
FLUORAPATITE CRYSTALS FOR POTENTIAL BIOMEDICAL 
APPLICATION 
Introduction 
Some lanthanide ions-doped materials can emit visible fluorescence when exited by 
near-infrared (NIR) laser.[23, 89] Typically, the sensitizers (usually Yb3+) successively absorb 
NIR excitations at a range of 700-1000 nm and transfer them to the activators (Ho3+, Er3+, 
or Tm3+ etc.), followed with short-wavelength emissions.[74, 90-92] Compared to organic 
luminophores and semiconductor quantum dots (QDs),[18, 21] these upconversion particles 
(UCPs) have such advantages as photostable, sharp visible emission bandwidth, and 
nontoxicity.[17, 31] UCPs are better for long-term bioimaging and cell tracking studies over 
organic luminophores which are subject to photobleaching and short excited state lifetimes, 
or QDs that show potential toxicity of cadmium and selenium, photoblinking, and short 
circulation half-time.[68, 72] In addition, different from conventional downconversion 
fluorescent labels requiring an ultraviolet or blue excitation wavelength, UCPs show deep 
penetration in tissues, multiplexing ability, and avoidance of tissue auto-fluorescence and 
possible fatal photodamage to cells.[21, 93] The UCPs are ideal fluorescent probes for a 
variety of biological applications, e.g. detection,[32, 94] imaging,[34, 35] cell tracking,[36] and 




[88] whereas their composition is 
not similar to biological apatite, which may block further in vivo biomedical applications. 
Herein we selected an apatite matrix that can not only house lanthanide ions but also 
possess good biocompatibility, and facilitate tissue-material interactions. Apatite crystals, 
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including hydroxyapatite [Ca10(PO4)6(OH)2, HA] and fluorapatite [Ca10(PO4)6F2, FA], are 
often used as substitutes of the inorganic component of bones and teeth,[4, 95] due to their 
structural similarity to bone mineral, excellent biocompatibility and bone-bonding 
bioactivity. Besides, HA and FA can act as good host materials for rare-earth doping as 
downconversion luminescent probes, such as FA-Eu[96] and HA-Tb[66]. Lanthanide ions 
have analogical radius as Ca2+ ions and high affinity to PO4
3- ions,[65, 70] which can ensure 
the success of rare-earth doping. We chose FA as the doping matrix, because F- ions can 
contribute materials with low phonon energies, which increase the number and probability 
of rare-earth luminescence transitions.[4] Though a few kinds of UCPs have appeared these 
years,[35, 71, 72] there are few reports on upconversion luminescence based on FA matrix. 
Combination of the upconversion fluorescent property of Yb/Ho ions, the excellent 
biocompatibility and typical crystal structure of FA will afford us to design a promising 
material for biomedical applications. The FA-based crystals have good crystal stability 
endowed by its hexagonal structure and F- ions. Thus, FA matrix and Yb3+/Ho3+ doping 
ions were chosen to synthesize FA:Yb3+/Ho3+ crystals and investigate the possibility of 
upconversion fluorescence. In addition, bone marrow mesenchymal stem cells (BMSCs) 
have shown great potential in tissue engineering,[37, 72, 97] which should be beneficial for 
future biomedical application and investigation on cell imaging and tracking of the 
FA:Yb3+/Ho3+ crystals. 
In this work, we reported the exploration for preparation and characterization of 
FA:Yb3+/Ho3+ upconversion crystals. The rare-earth co-doped crystals were synthesized by 
a modified hydrothermal method,[87, 98] followed by activating treatment at 700 °C. When 
excited under 980 nm NIR light, these crystals emitted bright green (543 nm) and red (654 
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nm) light, in a possible mechanism of excited state absorption (ESA) and energy transfer 
(ET). After surface coating with hydrophilic dextran, the crystals could exhibit distinct cell 
fluorescent imaging. 
Materials and methods 
Materials  
Ca(NO3)2·4H2O, Yb(NO3)3·6H2O, Ho(NO3)3·6H2O, Na3PO4·12H2O, NaF, 
octadecylamine, oleic acid, ethanol, and cyclohexane in AR grade were obtained from 
Beijing Chemical Reagents Company, China. Dextran 20,000 in AR grade was purchased 
from Sinopharm Chemical Reagent Company, China. Other chemical agents obtained from 
commercial routes were of analytical grade and used without further purification. 
Preparation of upconversion apatite nanocrystals co-doped with Yb3+ and Ho3+  
Octadecylamine (0.5 g) was dissolved in oleic acid (4 mL) and ethanol (16 mL) under 
magnetic stirring in a Teflon-lined autoclave (50 mL). Then aqueous solution of Ca(NO3)2 
(0.28 M, 7 mL), Ln(NO3)3 (Ln: 0.20M Yb
3+ + 0.02 M Ho3+, 2 mL), Na3PO4 (0.20 M, 7 mL) 
was added. For FA: Yb3+/Ho3+, additional NaF (0.24 M, 2 mL) was added. Afterwards, the 
mixture was agitated for 10 min, and hydrothermally treated at 160 °C for 16 h. After 
cooling to room temperature naturally, the white precipitate collected by centrifugation (10 
min at 2700 × g) was washed and activated at 700 °C in air for 2 h with a heating rate of 
1 °C /min. 
Coating of dextran on apatite nanocrystals  
The prepared rare-earth doped crystals (0.5 g) were added into a dextran solution (1g, 
7 mL) in a 10 mL round-bottom flask. The mixture was dispersed by ultrasonication, and 
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stirred for 2 h at room temperature to obtain a homogeneous phase. Then they were isolated 
by centrifugation (3 min at 2700 × g) and purified with distilled water and ethanol for three 
times separately. The product could be re-dispersed in aqueous solution. 
Characterization  
X-ray diffraction (XRD) powder patterns were acquired with a Philips X' Pert Pro 
MPD equipment in the 2θ range from 10º to 80º with Cu Kα radiation (λ = 1.5406 Å). TEM 
images of the crystals were collected on an FEI TecnaiG2 T20 instrument at 200KV. EDS 
data were obtained by both TEM and SEM (JEOL, JSM-5900LV). ICP-OES measurement 
was conducted on a Prodigy ICP-OES (Teledyne Leeman Labs), and every data point was 
expressed as a mean ± SD from triplicate dishes. The binding energy data were measured 
by XPS spectrum, AXIS Ultra DLD, Kratos, UK. FT-IR was recorded on a Perkin-Elmer 
6000 Fourier transformation spectrometer, with a wavenumber range of 400-4000 cm-1. 
The photoluminescence was recorded by the Hitachi F-7000 fluorescence 
spectrophotometer with an external 0-2 W adjustable diode laser integrated with an optical 
fibre (Beijing Hi-Tech Optoelectronic Co., China).  
Cytotoxicity assay 
Hela cells provided by Plastic Surgery Hospital of Peking Union Medical College, 
China were sued for the cytotoxicity assay. The cells were seeded in a 96-well flat-
bottomed microplate (5000 cells/well) and cultured in 100 μL growth medium at 37 °C and 
5% CO2 for 24 h. Cell culture medium in each well was then replaced by 100 μL cell 
growth medium, containing FA:Yb3+/Ho3+ crystals with concentrations of 100, 200, 400 
and 800 μg mL-1. After incubation for 1, 2, and 3 days at 37 °C, the crystals were washed 
with PBS for three times. 10 μL of CCK-8 dye and 100 μL of α-MEM cell culture medium 
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were added to each well, and cells were incubated further for 3 h at 37 °C. The absorbance 
at the wavelength of 450 nm was measured by a Varioskan Flash (Thermo Scientific). 
Upconversion bioimaging 
Bone marrow mesenchymal stem cells (BMSCs) were provided by Institute of Sports 
Medicine, Peking University Third Hospital, China. BMSCs were grown in α-MEM 
(Minimum Essential Medium, Alpha Modified) supplemented with 10% FBS (fetal bovine 
serum), and cultured at 37 °C under 5% CO2. BMSCs were seeded onto 35 mm coverglass-
bottom dishes and incubated in 2 mL of α-MEM at 37 °C for 24h. The culture medium was 
removed and the cells were incubated in 2 mL α-MEM containing FA:Yb3+/Ho3+ crystals 
(100 μg mL-1) at 37 °C for 24 h. After rinsing with PBS three times, cells were fixed with 
4% paraformaldehyde for 15 min. Upconversion fluorescence imaging was conducted 
under a multiphoton confocal microscope (Leica TCS SP8) at 980 nm. The green and red 
upconversion luminescence emission was collected at 540 ± 40 nm and 650 ± 40 nm, 
respectively. 
Statistical analysis 
The results were expressed as mean ± standard deviation (SD). Statistical comparisons 
between groups were analyzed by using one-way ANOVA test. A value of p < 0.05 was 
considered to be statistically significant. 
Results and discussion 
In order to evaluating the efficiency of the doping system, we started the preliminary 
investigation to screen the rare-earth elements and validate our hypothesis, that is, apatite 
can be used as matrix for rare-earth doping upconversion luminescence. The hexagonal 
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apatite crystal structure is selected as the doping matrix, including hydroxyapatite 
(Ca10(PO4)6(OH)2, HA), fluorapatite (Ca10(PO4)6F2, FA). Various rare-earth elements were 
tried according to literature and our research needs, we found that several co-doped 
lanthanides worked for upconversion (UC) apatite system, with red, green, and blue 
emissions for respective lanthanide, as shown in Table 3-1. The luminescence color 
depends on their unique electron orbitals. Because human eyes are sensitive to red and 
green colors, we select Yb/Ho (ytterbium/holmium) for upconversion co-dopants. The 
morphologies of some lanthanides co-doped FA crystals are shown in Figure 3-1. We also 
studied tri-doping apatite (Table 3-2), but here we will mainly focus on single doping and 
co-doping. As a result, apatite (HA and FA) can be used as matrix for rare-earth doping of 
down- and up-conversion luminescence. 
Table 3-1 Screening of the doping lanthanides for UC apatite system.  







Table 3-2 Fluorescence of tri-lanthanides doping apatite system. 
 UV NIR 
FA-Yb-Ho, Eu red green + red 
FA-Yb-Ho, Tb green green 
FA-Yb-Er, Eu red green 
FA-Yb-Er, Tb green green 
FA-Yb-Tm, Eu red - 




Figure 3-2 showed the XRD patterns of the FA:Yb3+/Ho3+ crystals after hydrothermal 
synthesis at 160 °C (A) and activation at 700 °C (B). It was noted that Figure 3-2A showed 
only an envelope curve, indicating a poorly crystallized apatite structure. Figure 3-2B 
showed a much higher crystallinity than Figure 3-2A, with sharp characteristic peaks at 
25.9° (002), 32° (211), 33.1° (300), 40.1° (212), and 46.7° (222), which matched well with 
the classic hexagonal phase of Ca10(PO4)6F2 (JCPDS No. 77-0120) belonging to the P63/m 
Figure 3-1 TEM morphologies of some lanthanides co-doped FA crystals. (A) FA-Yb-Er; 
(B) FA-Yb-Tm; (C) FA-Ce-Tb; (D) FA-Ce-Er; (E) FA-Yb-Tb; (F) FA-Yb-Nd.  
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space group (176). The interplanar spacing of the [002] lattice plane was 3.42 Å or 0.342 
nm. There were no impurity diffraction peaks or phases, such as those corresponding to 
rare-earth oxides, hydroxide, or fluoride, in the XRD patterns of the FA:Yb3+/Ho3+ crystals, 
implying that the doping rare-earth ions were incorporated into the lattice of the fluorapatite 
crystals. The lattice parameters were determined by a least squares refinement using JADE 
software, with a = b = 0.938 nm, c = 0.688 nm for crystals synthesized at 160 °C and a = b 
= 0.936 nm, c = 0.687 nm for crystals treated at 700 °C, which both were in accord with 
the FA standard card (a = b = 0.937, c = 0.688 nm). However, the lattice parameters (a and 
c) of the crystals treated at 700 °C were slightly smaller than those of the crystals 
synthesized at 160 °C. This result indicates that the treatment at 700 °C makes the crystal 
structure denser due to recrystallization. The hexagonal crystal structure of fluorapatite has 
good crystal stability, which would be helpful for stable fluorescence expression of the 
embedded rare-earth ions. 
 
Figure 3-2 XRD patterns of FA:Yb3+/Ho3+ crystals after hydrothermal synthesis at 160 °C 
for 16 h (A) and activation at 700 °C for 2 h (B).  
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Theoretically, we synthesized the rare-earth doped FA:Yb3+/Ho3+ crystals according 
to a molar ratio of XCa/YYb/ZHo = 100/20/2 in the design formula of (CaxYbyHoz)(PO4)6F2, 
through the reactions of Ca(NO3)2, Yb(NO3)3, Ho(NO3)3, Na3PO4, and NaF. Analytical data 
from the ICP-OES and SEM-EDS analyses (Table 3-3) illustrated that both Yb3+ and Ho3+ 
ions were incorporated into the FA crystals, and the measured molar ratio of XCa/YYb/ZHo 
in the synthesized FA:Yb3+/Ho3+ crystals was found to be 100/16/2.1 by ICP-OES or 
100/17/2.2 by EDS. The molar content of Yb3+ ions was slight lower than the theoretical 
value, while the content of Ho3+ ions was close to the theoretical value. Basically, the molar 
ratio of Ca/Yb/Ho is in accord with the theoretical ratio. 
Table 3-3 The molar ratio of Ca, Yb, and Ho in FA:Yb3+/Ho3+ crystals via ICP-OES and 
SEM-EDS. 
 SEM-EDS (mol %) ICP-OES (mol %) 
Theoretical Value 
(mol %) 
Ca/Yb/Ho 100/17/2.2 100/16/2.1 100/20/2 
 
After doping with Yb3+ and Ho3+ ions, the binding energies of Ca, P, and O in the 
doped FA crystals displayed a slight increase, as shown in the XPS data in Table 3-4. This 
trend indicates that the substitution of Yb3+ and Ho3+ ions for Ca2+ ions changes both the 
lattice parameters and the binding energy. This increase in binding energy suggests a 
stronger ion interaction in the doped apatite crystal structure. 
Table 3-4 The binding energy of ions in FA:Yb3+/Ho3+ crystals. 
 FA (eV) FA:Yb3+/Ho3+ (eV) 
Ca (2p) 346.8 346.9 
P(2p) 132.8 132.9 




It is known that the molecular formula of apatite or doped apatite is difficult to 
precisely replicate, especially when trivalent rare-earth ions replace divalent calcium ions. 
Figure 3-3 displays a schematic diagram for the three situations of Yb/Ho-embedding 
lattice models along the fluorine channel of an FA crystal cell. If the molar ratio of 
Ca/Yb/Ho = 100/16/2.1 is used to calculate the molecular formula of the FA:Yb3+/Ho3+ 
crystals, we obtain (Ca8.5Yb1.3Ho0.2)(PO4)6F2; namely, in 10 crystal cells of FA:Yb
3+/Ho3+, 
there are approximately 13 Yb3+ ions and 2 Ho3+ ions. Hence, each unit cell contains at 
least one Yb3+ ion, but only two unit cells contain both Yb3+ and Ho3+ ions. However, we 
will find a mismatch in the total valence in the formula (Ca8.5Yb1.3Ho0.2)(PO4)6F2 when 
compared to (Ca10)(PO4)6F2 of FA. For the balance of positive and negative valence, some 
Ca2+ vacancies or substitutions of O2- for F- should be present.[62] Moreover, a small number 
of monovalent sodium ions may exist to compensate for the valence mismatch. Indeed, Na+ 
ions (Na 1s, 1070.8 eV) were found by the XPS analysis. Therefore, the substitution of 
Yb3+ or Ho3+ ions for Ca2+ ions in fluorapatite crystals should result in several different 
situations. The lattice occupation of Yb3+ and Ho3+ ions in 10 crystal cells can be divided 
into three situations: 1) one Yb3+ ion replaces one Ca2+ ion in each of five unit cells; 2) two 
Yb3+ ions replace two Ca2+ ions in each of three unit cells; and 3) one Yb3+ ion and one 
Ho3+ ion replace two Ca2+ ions in each of two unit cells. For the first situation, a reasonable 
valence-balanced formula is (Ca9Yb)(PO4)6FO, or (Ca8YbNa)(PO4)6F2; for the second 
situation, the balanced formula could be (Ca7Yb2©)(PO4)6F2 (©-Ca vacancy) or 
(Ca6Yb2Na2)(PO4)6F2; for the third situation, a reasonable balanced formula is 




Figure 3-3 Schematic diagram of an Yb/Ho-embedding lattice model along the fluorine 
channel of FA crystal cell.  
 
We further investigated the crystal morphology and structure by TEM combined with 
EDS, HRTEM imaging, and SAED (Figure 3-4). As shown in Figure 3-4A, the 
FA:Yb3+/Ho3+ crystals after hydrothermal synthesis at 160 °C exhibited a fusiform 
morphology, with an average crystal size of approximately 26 nm by 250 nm. After 
activation treatment at 700 °C, these crystals still showed a slender shape with an average 
size of 16 nm by 286 nm (Figure 3-4B). The average center diameter of the nanocrystals 
decreased to 16 nm from 26 nm (a decrease of approximately 38%) while the average 
length increased to 286 nm from 250 nm (an increase of approximately 14%). This 
behavior indicates that recrystallization occurs during the heating process, which agrees 
well with the enhanced crystallinity shown in Figure 3-2B. Figure 3-4C provided a TEM-
EDS element mapping of the crystals, demonstrating the successful incorporation of Yb3+ 
and Ho3+ ions in the crystal structure. Figure 3-4D displayed a HRTEM image showing the 
presence of 2D lattice fringes for a single slender FA:Yb3+/Ho3+ crystal. The crystal showed 
preferential growth along the [002] direction, and the interplanar spacing of the [002] 
 
45 
lattice plane was 0.346 nm, in accord with the results (0.342 nm) from XRD analysis. 
Figure 3-4D also showed an inset of SAED pattern for the (002), (212), and (211) planes, 
which were in good agreement with the XRD pattern. The results confirm that the slender 
crystals exhibit a typical single crystal structure with uniform morphology and good 
crystallinity. The good dispersity and narrow size distribution of these crystals are expected 
to arise from the surfactant intervention during hydrothermal synthesis, the freeze-drying 
process, and the relatively lower activation temperature compared to previous studies 
conducted at 900 °C.  
 
Figure 3-4 TEM micrographs of FA:Yb3+/Ho3+ crystals after hydrothermal synthesis at 
160 °C (A) and activation at 700 °C (B); Element mapping by EDS (C), and HRTEM image 
of FA:Yb3+/Ho3+ single crystal with inset of SAED pattern (D).  
 
The activating treatment of rare-earth co-doped material is important for acquiring 
stable upconversion emission. We chose 700 °C for our treatment of Yb3+/Ho3+ co-doped 
apatite nanocrystals because it was found that at these temperature, the FA:Yb3+/Ho3+ 
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nanocrystals exhibited an obvious upconversion emission while maintaining good 
dispersity. For treatment at temperatures under 650 °C, almost no apparent upconversion 
emission was present. Above 750 °C, the nanocrystals melted and fused together to form a 
ceramic state. Thus, treatment at 700 °C enhances the crystallinity and structure stability 
of the FA:Yb3+/Ho3+ crystals, which especially promotes the upconversion effect. When 
excited by 980-nm NIR light, the Yb3+/Ho3+ co-doped crystals chiefly displayed two 
fluorescence emission bands, namely, a green band centered at 543 nm and a red band near 
654 nm, while the crystals that were not activated at 700 °C did not exhibit any obvious 
emission (Figure 3-5A). The 491-nm emission should be attributed to the 980-nm laser. To 
determine the number of photons (n) involved in the upconversion process, the pump 
power dependence of the luminescence intensity was investigated, as shown in Figure 3-
5B. The slope (n) values were 2.0 for both the green and red emission bands, demonstrating 
that a two-photon absorption process is involved in the upconversion emission. 
 
Figure 3-5 Upconversion emission spectra (A) of FA:Yb3+/Ho3+ crystals with (solid curve) 
and without (dashed curve) activation at 700 °C, and insets of laser confocal images; 
dependence of upconversion emission intensities on NIR pump power (B).  
 
Although a few Yb3+/Ho3+ co-doped upconversion materials have been reported,[99, 
100] biocompatible fluorapatite used in this experiment solely acts as a matrix for UCPs, 
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and thus, the upconversion mechanism needs further exploration. Here, we speculate a 
mechanism for the upconversion process of the FA:Yb3+/Ho3+ crystals upon NIR excitation 
at 980 nm (Figure 3-6). In the crystal lattice of FA, some Ca2+ sites are occupied by Yb3+ 
and Ho3+ ions. Because the content of Yb3+ ions is much higher than that of Ho3+ ions, each 
Ho3+ ion is surrounded by several Yb3+ ions in the FA crystal. First, the sensitizer Yb3+ ions 
are excited from the 2F7/2 to 
2F5/2 level upon the absorption of NIR photons (980 nm). The 
ions then transfer energy to the adjacent activator Ho3+ ions, exciting the ground Ho3+ ions 
to the 5I6 level. For green emission, Ho
3+ ions at the 5I6 level can be directly excited to the 
5F4, 
5S2 level by absorbing energy from the laser photons (excited state absorption, ESA).
[71] 
For red emission, the Ho3+ ions at the 5I6 level can drop to the 
5I7 level via nonradioactive 
phonon-assisted relaxation; they can then be excited to the 5F5 level by absorbing energy 
from the laser photons. The radioactive transfer of the Ho3+ (5F4, 
5S2) and Ho
3+ (5F5) ions 
to the ground state results in green emission centered at 543 nm and red emission centered 
at 654 nm, respectively. The Yb3+ ions surrounding the Ho3+ ions are helpful for facilitating 
excitation energy transfer and are also separated by a considerable number of optically 
inactive Ca2+ ions to avoid energy migration to capture traps. 
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Figure 3-6 Schematic energy-level diagram of Ho3+ and Yb3+ ions and upconversion 
luminescence mechanism for FA:Yb3+/Ho3+ crystals.  
 
The proliferation of cells cultured with different dosages of FA:Yb3+/Ho3+ crystals 
was evaluated using a cell counting kit-8 (CCK-8) assay. Figure 3-7 showed that the cell 
proliferation for different dosage groups increased markedly and continuously with time, 
showing a normal growth trend, even at a high dosage of 400 μg mL-1. On Day 1, all 
experimental groups showed proliferation comparable to the control (p > 0.05). On Day 3, 
although the cell proliferation for the 100 and 200 μg mL-1 dosage groups were lower than 
that of the control and the 400 and 800 μg mL-1 dosage groups (p < 0.05), they still 
exhibited a normal growth status. This result indicates that the cytotoxicity of the rare-earth 




Figure 3-7 CCK-8 assay of cell proliferation after cultured with different dosages of 
FA:Yb3+/Ho3+ crystals for 1, 2, and 3 days, error bars represent mean ± SD from triplicate 
experiments, p < 0.05 (* vs. control, ^ vs. 100 μg/mL, # vs. 200 μg/mL).  
 
To explore the potential of FA:Yb3+/Ho3+ crystals for future biomedical applications, 
we used hydrophilic dextran to graft the surface of these crystals for cell imaging. Figure 
3-8 showed the FT-IR spectra of the FA:Yb3+/Ho3+ crystals treated at 700 °C, the dextran 
and dextran-grafted FA:Yb3+/Ho3+ crystals. The absorption peaks at 3411 and 1652 cm-1 in 
Figure 3-7C attribute to the typical stretching vibration and bending vibration of the -OH 
groups, and the absorption peak at 2930 cm-1 is the typical stretching vibration of C-H in 
dextran. By comparing Figure 3-8C with Figure 3-8B, the presence of -CH2 and -OH peaks 
and the peak shift (e.g., from 2926 to 2930 cm-1 for -CH2 groups) provide evidence of 
successful grafting of hydrophilic dextran on the crystals. The peak shift should be caused 
by the bonding or interaction between the crystals and dextran. Other peaks at 1043 and 
960 cm-1 (asymmetrical stretching vibration) and 606 and 575 cm-1 (bending vibration) 
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correspond to the PO4
3- groups, similar to the FA:Yb3+/Ho3+ crystals without a grafting 
(Figure 3-8A). The dextran-grafted FA:Yb3+/Ho3+ crystals are small in size and exhibit 
distinct upconversion fluorescence, good cytocompatibility, and crystal stability, making 
them suitable for bioimaging investigation. 
 
Figure 3-8 FTIR spectra of the FA:Yb3+/Ho3+ crystals treated at 700 °C (a), dextran (b) and 
dextran-grafted FA:Yb3+/Ho3+ crystals (c). 
 
A combination of 100 μg mL-1 dextran-grafted FA:Yb3+/Ho3+ crystals and BMSCs 
was used to investigate the possibility of cell imaging. The results of in vitro cell imaging 
demonstrated the cellular uptake of the crystals, as shown in Figure 3-9. When BMSCs 
treated with these crystals were exposed to 980-nm excitation, the cells showed strong 
cellular upconversion fluorescence. The cell morphology and cytoplasm could be clearly 
observed. The green (A) and red (B) fluorescent images of the cells matched well with the 
bright-field image of the cells (C) and provided clear overlap images (D). Moreover, the 
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upconversion luminescence of the FA:Yb3+/Ho3+ crystals was stable and reproducible; the 
samples maintained reproducibility after 7 days. This result indicates the feasibility of 
using these upconversion crystals for cell imaging and tracking via their easy translocation 
into the cytoplasm of cells. Furthermore, the optical absorption of cellular components 
under NIR excitation is much lower than that for UV or visible light, which is helpful for 
reducing photodamage and for improving the sensitivity due to the absence of auto-
fluorescence.[97] These features can also pave the way for imaging and tracking cells with 
multilineage differentiation. 
 
Figure 3-9 Multiphoton confocal luminescence images (excited by 980 nm light) of 
BMSCs incubated with 100 μg mL-1 dextran-grafted FA:Yb3+/Ho3+ crystals for 24 h at 
37 °C. The photos showed green (A) and red (B) upconversion luminescence images of 
BMSCs, bright-field of the cells (C) and overlay image (D) of green plus red. The green 
and red upconversion luminescence emission was collected at 540 ± 40 nm and 650 ± 40 
nm, respectively. 
 
In addition to cell imaging, the Yb3+/Ho3+ co-doped apatite nanocrystals will have 
broad applications in biomedical fields. Using the good biocompatibility, bone-bonding 
bioactivity, and upconversion fluorescence of these rare-earth doped apatite nanocrystals, 
we can produce porous composite scaffolds with biodegradable polymers to investigate the 
process of bone repair and regeneration, determine whether synthetic apatite nanocrystals 
can incorporate into newly formed bone, reveal the bone-biomaterial interface via 
fluorescent imaging, trace the degradation of scaffolds, distinguish the scaffold material 
from bone tissue in histological sections, etc. Therefore, investigations on the upconversion 
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properties of such Yb3+/Ho3+ co-doped apatite nanocrystals have significance in scientific 
studies and biomedical applications. 
To identify the uptake of FA: Yb3+/Ho3+ crystals into BMSCsGFP, we performed TEM 
and two-photon confocal microscopy imaging. TEM imaging was obtained after 
BMSCsGFP were incubated for 24 h in 50 mg mL-1 FA: Yb3+/Ho3+ modified medium and, 
as shown in Figure 3-10A, confirmed a strong uptake of crystals in the cytoplasm of the 
BMSCsGFP, where strong-dark electron-dense nanoparticles are easily observed (indicated 
by red arrows). The emission spectrum of GFP (Em 503 ± 40 nm) is partly overlapped with 
the upconversion luminescence of FA: Yb3+/Ho3+ crystals at 543 ± 20 nm (B). Therefore, 
in the following experiments, we chose GFP and upconversion luminescence of FA: 
Yb3+/Ho3+ crystals at 654 ± 60 nm to track the BMSCsGFP. As shown in Figure 3-9C, 
BMSCsGFP treated with 50 mg mL-1 FA: Yb3+/Ho3+ crystals, demonstrated strong cellular 
upconversion fluorescence and GFP when excited at 980 nm. Meanwhile, two-photon 
confocal microscopy scanning of BMSCsGFP after treatment with 50 mg/mL FA: Yb3+/Ho3+ 





Figure 3-10 Uptake of FA:Yb3+/Ho3+ crystals into BMSCsGFP. (A) TEM images of 
BMSCsGFP after incubation with 50 mg mL-1 FA:Yb3+/Ho3+ crystals for 24 h at 37 °C. (Red 
arrows) (B) Fluorescence spectra of GFP and FA:Yb3+/Ho3+ crystals. (C) Two-photon 
confocal luminescence images (excited by 980 nm light) of BMSCsGFP treated as in (A). 
(D) Two-photon confocal microscope scanning of BMSCsGFP after treatment with 50 mg 
mL-1 FA:Yb3+/Ho3+ (excited by 980 nm light). (White triangle). Adapted with permission 
from Hu.[101] Copyright (2015) Elsevier. 
 
After four weeks’ implantation, newly formed tissues displayed a translucent and 
cartilage-like appearance [Figure 3-11A (a)]. We observed no obvious difference in the 
gross appearance between the control group and the FA: Yb3+/Ho3+ treated group [A (b)]. 
H&E staining [B (a and b)] revealed a well-defined construct of transplanted cells in the 
DCCBM scaffold in vivo. After staining with toluidine blue [B (c and d)], the BMSCsGFP 
from the control group and the FA: Yb3+/Ho3+ treated group displayed uniform, positive 
staining for cartilaginous ECM. In order to determine cartilaginous differentiation, we used 
immunohistochemical staining to detect cartilage-related protein Col2A (B (e and f). The 
results were consistent with toluidine blue staining, indicating that BMSCsGFP treated with 
50 mg mL-1 FA: Yb3+/Ho3+ also differentiated into chondrocytes in vivo. 
Further, we detected GFP fluorescence and upconversion fluorescence of BMSCsGFP 
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using two-photon confocal microscopy (excited at 980 nm). As shown in Figure 3-12A and 
B, the upconversion fluorescence of FA: Yb3+/Ho3+ crystals was observed at both 4 weeks 
and 12 weeks post transplantation; while GFP fluorescence was significantly decreased at 
12 weeks post BMSCsGFP transplantation, compared with that of 4 weeks. These results 
imply that FA: Yb3+/Ho3+ crystals have high biocompatibility and stability and can be 





Figure 3-11 In vivo chondrogenic differentiation capacity of BMSCsGFP after treatment 
with 50 mg mL-1 FA:Yb3+/Ho3+ crystals. (A) Mass growth of cartilage constructs after four 
weeks in vivo. (B) (a, b) HE staining showing cell morphology and distribution. (c, d) 
Toluidine blue staining. (e, f) Immunohistological staining for type II collagen. Adapted 




Figure 3-12 Two-photon confocal luminescence images of BMSCsGFP transplanted in nude 
mouse. (A and B) BMSCsGFP treated with or without 50 mg mL-1 FA:Yb3+/Ho3+ for two 
days were seeded on the perforated DCCBM scaffold and induced in the chondrogenic 
differentiation medium for five days, before DCCBM was subcutaneously implanted in 
nude mice. BMSCsGFP were observed by two-photon confocal microscope (excited at 980 
nm) at 4 and 12 weeks after transplantation, respectively. Adapted with permission from 




Fluorapatite crystal matrix was chosen for doping of Yb3+ and Ho3+ ions for the first 
time, which have successfully realized the upconversion luminescence. The substitution of 
Yb3+ and Ho3+ ions for Ca2+ ions results in the change of both lattice parameters and 
binding energy. The proposed lattice models demonstrate the importance of coexistence of 
different lattice substitution of Yb3+ and Ho3+ ions in the FA crystal structure. When excited 
by 980 nm near-infrared light, the FA:Yb3+/Ho3+ crystals display bright green and red 
emission with narrow emission bands at 543 and 654 nm, respectively. After surface 
coating with hydrophilic dextran, the crystals exhibit distinct cell fluorescent imaging by 
entering the cytoplasm of cells. Our collaborator Dr. Xiaoqing Hu from Peking University 
Third Hospital determined the chondrogenic differentiation potential of the labeled 
BMSCsGFP using real-time RT-PCR analysis, histological assessment and 
immunohistochemistry. The continuous luminescence was detected after 12 weeks post 
transplantation from the FA: Yb3+/Ho3+ upconversion crystals, while the GFP signal was 
significantly decreased after this time. The rare-earth doped crystals with good 
cytocompatibility, stable crystal structure, fluorescent repeatability and bioactivity have 




CHAPTER 4 LANTHANIDES DOPED UPCONVERSION 
NANOAPATITE FOR SMART BIOIMAGING DURING BONE 
REGENERATION 
Introduction 
Over the past decade, considerable interest has been given to the design of scaffolds 
for bone tissue engineering, which is essential as a guiding structure for bone in-growth.[102] 
In principle, apatite scaffolds or apatite/polymer composite scaffolds can bond with bone 
tissues and are expected to degrade while the newly formed bone tissue infiltrates.[83] 
Hematoxylin and eosin (H&E) or Masson’s staining are usually adopted to distinguish the 
newly formed bone tissue on the histological section of scaffolds implanted in vivo.[3] 
However, it is still difficult to clearly distinguish the scaffold material and material-tissue 
interface on these histological sections. Previous studies have used environmental scanning 
electron microscopy (ESEM) to distinguish the newly mineralized bone from the biphasic 
calcium phosphate (BCP) scaffold during osteogenesis based on the image grey values.[8] 
However, this method only provides a limited field of view, hardly allowing a full 
correlative investigation on changes in the ultrastructure over a macroscopic sample. 
Small-angle X-ray scattering (SAXS) remains constrained to isotropically oriented 
ultrastructures.[9] Therefore, novel methods are needed to distinguish the scaffold from the 
newly formed bone tissue on histological sections. Incorporating fluorescence into 
scaffolds is one prospective strategy for achieving this purpose. 
Fluorescent probes play a key role in bioimaging to label the target and amplify 
fluorescent signal. The fluorophore can absorb light and jump to an excited state and then 
return to the ground state by emitting lower energy light. This energy difference between 
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excitation and emission is called the Stokes shift.[17] As microscopes have become more 
advanced, traditional organic fluorophores such as green fluorescent protein (GFP) have 
become disadvantaged in their probe brightness and stability.[18] Besides, cells may have 
many fluorescent components of their own, resulting in unwanted background fluorescence 
known as auto-fluorescence. Newly developed semiconductor quantum dots (QDs) have 
also shortcomings in toxicity, photo-blinking, and short circulation half times.[21] Recently, 
lanthanide doped upconversion particles have drawn great attention due to their 
photostability, high contrast and low toxicity.[22, 23] The upconversion process was first 
proposed in 1959,[29] which involves anti-Stokes shifts by upconverting low energy 
photons into high energy photons. When excited by a 980 nm NIR laser, the sensitizers 
(Yb3+ ions) can transfer energy to the nearby activators (Ho3+, Er3+, and Tm3+ ions) to emit 
short-wavelength luminescence. Lanthanide ions are good candidates for upconversion 
luminescence because of their multiple metastable electron states. Moreover, near infrared 
(NIR) light can penetrate deeper in the body and shows less damage to cells than UV and 
blue light. Upconversion particles as biomarkers are attractive for use in design of new 
probes and bioimaging applications. Work has been performed on multicolor tuning of 
upconversion probes and minimizing heating effect of excitation.[35, 73] Additional studies 
have shown applications in long-term real-time cell imaging[68] and in small-animal 
imaging.[74] However, there have so far been no reports on the potential of upconversion 
materials in labeling scaffold materials and the material-tissue interface. 
The inorganic mineral of human hard tissues is mainly composed of nanoapatite.[2] 
Synthetic nanoapatite including hydroxyapatite [Ca10(PO4)6(OH)2, HA] and fluorapatite 
[Ca10(PO4)6F2, FA] are good candidates for repair of bone and teeth due to their structural 
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similarity to the mineral, excellent biocompatibility, and high osteogenicity.[103-105] Both 
HA and FA crystals have a hexagonal structure in which the Ca2+ sites can be easily 
substituted by other metal ions, such as Mg2+, Sr2+, Ln3+, etc.[77, 106, 107] The apatite structure 
has been employed as a stable host matrix for lanthanide doping in previous studies on both 
downconversion[82, 108] and upconversion nanoparticles.[101, 109] The successful doping of 
lanthanides result from their high affinity to PO4
3- ions and a similar ionic radius to 
calcium.[65] We hypothesize that lanthanide-doped apatites with stable upconversion 
luminescence and bone-bonding capacity will provide a novel method for distinguishing 
implanted bone scaffold materials from host tissue, as well as show their respective 
distribution. This method can also be useful for long-term in vivo tracking of implanted 
material or scaffolds and their degraded fragments. 
In this study, lanthanide Yb3+ and Ho3+ co-doped fluorapatite (FA:Yb3+/Ho3+) and 
hydroxyapatite (HA:Yb3+/Ho3+) nanoparticles with varying dopant concentration were 
prepared by hydrothermal synthesis at 180 °C for 16 h, and activated at 700 °C for 2 h. The 
upconversion emissions of these nanoparticles were detected by fluorescence spectrometry. 
Cell proliferation was analyzed before performing animal experiment. Histological 
sections of the harvested in vivo samples treated by Masson’s staining were imaged by 
inverted fluorescence microscopy and laser confocal microscopy, to distinguish the 
implanted material from newly formed bone tissue and track the material’s distributions 
during osteogenesis in vivo. 
Materials and methods 
Materials  
Ca(NO3)2·4H2O, Yb(NO3)3·6H2O, Ho(NO3)3·6H2O, Na3PO4·12H2O, NaF, and 
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ethanol at AR grade were obtained from Beijing Chemical Reagents Company, China. All 
other chemical agents obtained from commercial routes were of analytical grade and used 
without further purification. 
Preparation of FA:Yb3+/Ho3+ and HA:Yb3+/Ho3+ nanoparticles 
The Yb3+/Ho3+ co-doped apatite precipitates were hydrothermally synthesized 
referring to previous method.[109] Briefly, an aqueous solution of Na3PO4 (0.20 M, 7 mL) 
and NaF (0.24 M, 2 mL, for FA only) was slowly dripped into a solution of Ca(NO3)2 (0.28 
M, 7 mL), Yb(NO3)3 (0.10 M, 2 mL), and Ho(NO3)3 (0.005~0.03 M, 2 mL). Surfactant like 
octadecylamine, oleic acid or ricinoleic acid was selectively added during synthesis 
according to experimental needs. The molar concentration of Yb3+ and Ho3+ ions relative 
to Ca2+ ions was set as 10:0.5 to 10:3 (Table 4-1). Afterwards, the mixture was agitated for 
10 min and hydrothermally treated at 180 °C for 16 h. After cooling to room temperature, 
a white precipitate was collected by centrifugation (10 min at 2700 × g), and rinsed in DI 
water and ethanol, respectively. Samples were freeze-dried and activated at 700 °C for 2 h 
at a heating rate of 1 °C /min.  
Table 4-1 Concentrations of the co-doped Yb3+ and Ho3+ ions relative to Ca2+ ions in 
FA:Yb3+/Ho3+ and HA: Yb3+/Ho3+ materials. 
Sample Yb3+ (mol%) Ho3+ (mol%) 
1 10 0.5 
2 10 1 
3 10 2 





X-ray diffraction (XRD) powder patterns were acquired with a Philips X’ Pert Pro 
MPD (Netherland) apparatus over a 2θ range of 10º to 80º using Cu Kα radiation (λ = 
1.5406 Å). TEM images of the particles were measured by an FEI TecnaiG2 T20 
instrument (USA) at 200 kV along with EDS, HRTEM image and SAED pattern. FT-IR 
spectra were recorded on a Perkin-Elmer 6000 Fourier transformation spectrometer (USA), 
with a wavenumber range of 500-3500 cm-1. The photoluminescence behavior was 
recorded using a Hitachi F-7000 fluorescence spectrophotometer (Japan) attached with an 
external 2W adjustable diode laser (Beijing Hi-Tech Optoelectronic Co., China). 
Cell culture 
MG63 osteoblast-like cells were used to evaluate the biological properties of 
FA:Yb3+/Ho3+ powder. MG63 cells were provided by the West China Hospital. The cells 
were cultured in F12 medium (Cell culture grade, Biowhittaker, Walkersville, MD) 
supplemented with 10% (v/v) calf serum (Cell culture grade, Gibco, Rockville, MD), 1% 
penicillin/streptomycin and 1% L-glutamine. Cells were subcultured once a week using 
Trypsin/PBS and maintained at 37 °C in a humidified atmosphere of 5% CO2 in air. The 
medium was changed every three days. 
Cell viability 
A serial dilution was performed from an 800 μg/mL stock solution of FA:Yb3+/Ho3+. 
F12 medium was added in a 1:1 ratio, resulting in a final FA:Yb3+/Ho3+ concentration range 
of 100-400 μg/mL. MG63 cells with the FA:Yb3+/Ho3+ solution were seeded onto 96-well 
tissue culture plates (Corning, USA) with a density of 2×104 cells/well). Afterwards, the 
seeded samples were cultured in a humidified incubator (37 °C, 5% CO2) for 11 days, and 
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the medium was changed every two days. MG63 cells cultured in F12 served as the control. 
Cell viability was measured as a function of mitochondrial nicotinamide adenine 
dinucleotide (NADH)/nicotinamide adenine dinucleotide phosphate (NADPH)-dependent 
dehydrogenase activity. The activity was measured by the conversion of 3-(4,5-
dimethylthiazol-2-gl)-5-(3-carboxymethoxylphenyl)-2-(4-sulphophenyl-2H) tetrazolium 
salt (MTT) into a soluble formazan dye with the CellTiter 96 Aqueous non-radioactive cell 
proliferation assay (Promega, USA). After 1, 4, 7, and11 days following cell seeding, the 
culture medium was removed and 200 μL of MTT-F12 solution was added to each well. 
Following incubation at 37 °C for 4 h in a fully humidified atmosphere at 5% CO2 in air, 
MTT was taken up by active cells and reduced in the mitochondria to an insoluble purple 
formazan granule. Subsequently, the media was discarded and the precipitated formazan 
was dissolved in DMSO (150 μL/well). Optical density of the solution was evaluated using 
a microplate spectrophotometer (PerkinElmer wallac 1420, USA) at a wavelength of 570 
nm. The results are presented as mean ± SD from triplicate wells. 
In vivo experiment 
Six adult New Zealand white rabbits were randomly divided into three groups (2, 4, 
and 6 months; n=2 in each group). Anesthesia was induced by ear vein injection. After 
shaving and disinfection of the hind limbs, a cylindrical bone defect (diameter 6 mm, depth 
10 mm) was drilled on the left distal femoral condyle (Figure 4-1). FA:Yb3+/Ho3+ powder 
was implanted into the defects and harvested with surrounding tissue at 2, 4, and 6 months 
after implantation. The harvested samples were fixed in 10 % formalin, dehydrated through 
gradient ethanol, then embedded with PMMA and cut into sections of 3 μm in thickness, 
subsequently stained with Masson’s staining and observed under a light microscope 
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(TE2000-U, Nikon, Japan). The fluorescent images were collected via inverted 
fluorescence microscope (Ti-U, Nikon, Japan) and two-photo confocal microscope (LSM 
780 NLO, ZEISS, Germany).   
 
Figure 4-1 The created bone defect of rabbit distal femoral condyle, and implantation of 
FA:Yb3+/Ho3+ powder into the defect. 
 
Statistical analysis 
All results are expressed as mean ± standard deviation (SD). Statistical comparisons 
between groups were analyzed by using one-way ANOVA test. A value of p < 0.05 was 
considered to be statistically significant. 
Results and discussion 
The morphologies of hydrothermally synthesized Yb3+/Ho3+ co-doped FA and HA 
particles were shown in Figure 4-2. After hydrothermal synthesis, the precipitates 
presented rod-like morphology when surfactant was used in the synthesis [Figure 4-2 (A, 
B)]. By adjusting the content of NaOH or pH, nanospheres (Figure 4-2C) or nanowire 
(Figure 4-2D) could be obtained. After activation at 700 °C for 2 h, the rod nanoparticles 
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showed slight shrinkage than the as-prepared ones, like the insets in Figure 4-2 (A, B). It 
has been found that fluorapatite has a more stable crystal structure than hydroxyapatite. 
Different nano-morphology may adapt to different applications. The elaborate nanorods 
may suit for cell imaging, the nanospheres could be microcarrier of drug or protein 
molecules, the nanowire could be used to make biocomposite. The nanorods may be also 
suitable for in vivo animal experiments as tracking fillers of bone defect or composite 
scaffolds, besides for possible detection and diagnostic kit. We found that these apatite 
nanoparticles could present both green and red upconversion fluorescence when excited by 
980 nm NIR light, which may provide more choice in biomedical applications. 
 
Figure 4-2 The morphologies of FA:Yb/Ho nanorods (A), HA:Yb3+/Ho3+ nanorods (B), 
FA:Yb/Ho nanospheres (C) and FA:Yb/Ho nanowire (D) after hydrothermal synthesis. 
Insets in (A) and (B) are the images after thermal activation. 
 
To detect and compare upconversion signals, the upconversion emissions of activated 
Yb3+/Ho3+ co-doped FA and HA particles with varying dopant concentrations were 
 
66 
investigated under 980 nm excitation with 400 mW pump power. Figure 4-3 showed the 
upconversion luminescence spectra of FA:Yb3+/Ho3+ and HA:Yb3+/Ho3+ with a fixed Yb3+ 
concentration at 10 mol% and varying Ho3+ concentrations from 0.5 to 3 mol%. The green 




5I8, respectively. By altering the doping concentration of Ho
3+ ions, we 
observed different upconversion emission behaviors. For the Yb3+/Ho3+ co-doped FA 
matrix, the green emission had a much higher intensity than the red emission, and the peak 
width of green emission was relatively narrower (Figure 4-3A). The FA:10Yb3+/0.5Ho3+ 
sample showed the strongest emission intensity, with both the green and red emissions 
decreasing with increasing Ho3+ ion concentration from 0.5 to 3 mol%. This may have been 
a result of the concentration-dependent quenching. Others have also reported a similar 
phenomenon.[110, 111] Figure 4-3B showed the upconversion emission spectra of 
HA:Yb3+/Ho3+, in which the peak intensity of red emission was dominant and the 
HA:10Yb3+/1Ho3+ sample had the highest emission intensity. Both red and green emissions 
had the same variation trend when the concentration of Ho3+ ions was increased. The 
intensity first increased with Ho3+ ion concentration from 0.5 to 1 mol%, and then 
decreased with Ho3+ ion concentration from 2 to 3 mol%. Ho3+ upconversion emission was 
attributed to the energy transfer upconversion (ETU) process. Under 980 nm near-infrared 
excitation, the Yb3+ ions (sensitizer) absorbed energy from the 980 nm laser and transferred 
it to adjacent Ho3+ ions (activator) that emitted two-photon upconversion luminescence[109, 
112] (Figure 4-3C). Figure 4-3D illustrated the upconversion emission under 980 nm 
excitation with varying pump power from 300 to 1,500 mW for the FA:10Yb3+/0.5Ho3+ 
sample. The intensities of green and red emissions were enhanced by increasing pump 
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power. These changes were more rapid and evident during the initial period of increasing 
pump power. 
 
Figure 4-3 Upconversion luminescence spectra of (A) FA:Yb3+/Ho3+ and (B) 
HA:Yb3+/Ho3+ with various dopant concentrations. (C) Upconversion energy transfer 
diagram of Yb3+ and Ho3+ ions under 980 nm excitation. (D) Upconversion spectra of the 
FA:10Yb3+/0.5Ho3+ with varying pump power. 
 
The difference in green and red emission behavior between FA:Yb3+/Ho3+ and 
HA:Yb3+/Ho3+ should be dependent on their lattice structure and composition,[113] as well 
as the distance-related efficiency of energy transfer from Yb3+ to Ho3+ ions.[113] For 
upconversion materials, doping usually involves an insulating host matrix embedded with 
trace amount of lanthanides in its lattice. FA and HA have the same hexagonal crystal 
structure belonging to the P63/m (176) space group, so the difference in dominant emissions 
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between the FA (green) and HA (red) matrix may have been caused by the difference of F- 
ions and OH- ions. When the F- ion substitutes for the OH- ion with smaller ionic radius 
and stronger electronegativity, the hexagonal apatite crystal structure becomes more 
compact and binding energy increases.[108] In addition, F- ions have a much lower photon 
energy compared to OH- ions, which are able to quench fluorescence due to their high 
vibration frequency.[80, 81] The stronger red upconversion is often reported by other 
researchers with a relatively high concentration of Ho3+ ions and is attributed to cross-
relaxation among different levels of Ho3+ ions, which may inhibit green upconversion.[114, 
115] Small changes in crystal structure can also affect the efficiency of Yb3+ to Ho3+ energy 
transfer and result in the alteration of green and red emissions. Figure 4-4 showed a lattice 
model for Yb3+/Ho3+ co-doped FA and HA crystal cells along the fluorine channel and 
hydroxyl channel of the hexagonal apatite structure. In the hexagonal apatite structure, 
there are two calcium triangles surrounding the two F- ions or two OH- ions. When one 
Yb3+ ion and one Ho3+ ion substitute for two Ca2+ ions in a calcium triangle, a Ca2+ vacancy 
occurs for the charge balance, and the ion substitutions will change the lattice parameters. 
Compared to the lattice parameters of the pure FA sample (a = b = 9.449 Å, c = 6.883 Å), 
the FA:10Yb3+/0.5Ho3+ sample showed smaller lattice parameters of a = b = 9.382 Å, c = 
6.882 Å. After activation at 700 °C, the parameters further reduce to 9.361 Å and 6.868 Å. 
The decrease in unit cell dimension suggests more stable crystal structure and stronger ion 
interaction in the co-doped apatite lattice, which can enhance the distance-related 
efficiency of energy transfer from Yb3+ to Ho3+. Without thermal activation, the Yb3+/Ho3+ 
co-doped apatite samples appeared unstable and demonstrated weak upconversion 




Figure 4-4 Lattice model for FA:Yb3+/Ho3+ (A) and HA:Yb3+/Ho3+ (B) crystal cells along 
the fluorine channel and hydroxyl channel of hexagonal apatite structure; the broken circle 
represents the Ca2+ vacancy. 
 
Fluorescent images of FA:10Yb3+/0.5Ho3+ and HA:10Yb3+/1Ho3+ were obtained by 
inverted fluorescence microscope (Ti-U, Nikon, Japan) under 980 nm near-infrared 
excitation (Figure 4-5). The green image looked more clear and distinguishable, but the red 
image was blurrier, although the brightness of green and red glows was both strong. 
Therefore, we selected and concentrated on the FA:10Yb3+/0.5Ho3+ sample for further 
animal experiments due to its dominant green emission and optimal image resolution, and 
nanorod morphology. In addition, a dominant upconversion green emission could avoid the 
auto-fluorescence of tissues and green fluorescence of some biomedical polymer matrix 
under excitation of UV and blue lights, as well as distinguish itself from the red color of 
stained bone tissue on histological sections when comparing superimposed upconversion 





Figure 4-5 Green and red fluorescent images of FA:10Yb3+/0.5Ho3+ (A, B) and 
HA:10Yb3+/1Ho3+ (C, D). 
 
The crystal structure and morphology of the FA:10Yb3+/0.5Ho3+ sample were 
examined using XRD, FT-IR, HRTEM and EDS. Figure 4-6A showed the XRD pattern of 
the FA:10Yb3+/0.5Ho3+ sample, in which the diffraction peaks match well with the classical 
hexagonal phase of FA (Ca10(PO4)6F2, ICDD 77-0120). The sharp characteristic peaks at 
25.9°, 32°, 33.1°, 40.1°, 46.7°, and 49.7° corresponded directly to the (002), (211), (300), 
(212), (222), and (213) lattice planes, respectively. There were no impurity diffraction 
peaks or phases in the XRD pattern, indicating that the Yb3+ and Ho3+ ions had been 
successfully incorporated into the FA crystal lattice. The FT-IR spectrum in Figure 4-6B 
illustrated the asymmetrical stretching vibration peak at 1042 cm-1 and the bending 
vibration peaks at 606 and 576 cm-1 corresponding to PO4
3- groups of the FA crystal 
structure. Figure 4-6C displayed a HRTEM image with presence of 2D lattice fringes on 
single rod-like FA:Yb3+/Ho3+ crystal, the interplanar spacing of (002) lattice plane is 0.347 
nm, which refers the crystal prefers to grow along the (002) direction. The inset SAED 
pattern shows (002) and (211) planes, which is in well agreement with that observed in 
XRD pattern. Both Yb3+ and Ho3+ ions were present in the EDS element mapping (Figure 
4-6D) of the crystal, demonstrating the successful incorporation of Yb3+ and Ho3+ ions into 




Figure 4-6 XRD pattern (A), FT-IR spectrum (B), HRTEM image (C, inset is the SAED 
pattern), and EDS element mapping (D) of the FA:10Yb3+/0.5Ho3+ sample. 
 
To evaluate the cytocompatibility of FA:10Yb3+/0.5Ho3+, we used the MTT assay to 
investigate cell viability of MG63 cells cultured with various concentrations of 
FA:10Yb3+/0.5Ho3+ nanoparticles for 1, 4, 7, and 11 days. As shown in Figure 4-7A, the 
Yb3+/Ho3+ co-doped FA nanoparticles had no negative influence on the viability of MG63 
cells at concentrations of 100, 200, and 400 μg/mL. The cells proliferated with culture time; 
on day 1 and day 4, all experimental groups and the control showed similar optical density 
(OD) values. On days 7 and 11, the experimental groups still exhibited normal growth 
status with OD values slightly lower than the control (*p < 0.05). We also demonstrated 
that the upconversion nanoparticles could penetrate into cells after grafting dextran onto 
the surface of the nanoparticles.[101] Figure 4-7B illustrated the green luminescence of cells 
incubated with 100 μg/mL of FA:Yb3+/Ho3+ nanoparticles obtained by a two-photon 
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confocal microscopy under 980 nm excitation. The cell morphology and cytoplasm could 
be clearly observed through the stable upconversion luminescence. The low absorption of 
cell components and tissues under NIR excitation indicated additional advantages in 
avoiding photodamage and auto-fluorescence for the in vivo study.[116] 
 
Figure 4-7 Cell viability of MG63 cells cultured with different dosages of 
FA:10Yb3+/0.5Ho3+ nanoparticles for 1, 4, 7, and 11 days (A), error bars represent mean ± 
SD from triplicate experiments, p < 0.05 (* vs. control, ^ vs. 100 μg/mL, # vs. 200 μg/mL). 
Two-photon confocal luminescence images of MG63 cells treated with 100 μg/mL 
FA:Yb3+/Ho3+ nanoparticles (B), with green luminescence collected at 500-550 nm. 
 
Figure 4-8 showed a light microscopy image of bone tissue without staining (A), and 
the corresponding fluorescent images under various excitations. The bone tissue presented 
weak blue, green, and red (B-D) auto-fluorescence under excitation of UV, blue, and green 
lights, respectively. There was no luminescence or auto-fluorescence under the excitation 
of 980 nm near-infrared laser light (E).  
 
Figure 4-8 The light microscopy image (A) of bone tissue without staining and 
corresponding fluorescent images under excitation of UV (B), blue (C), green (D), and 980 




After Masson’s staining, matured bone tissue and growing bone tissue on histological 
sections were indicated in blue color and red color, respectively, under observation of light 
microscopy (Figure 4-9A). From the stained section, it is hard to distinguish clearly the 
implanted material, the material distribution, and the material-tissue interrelation. Figure 
4-9B was the overlap image of the tissue light image and the upconversion green 
fluorescent image of the implanted FA:10Yb3+/0.5Ho3+ particles under 980 nm NIR 
excitation, which clearly showed the particles’ distribution. In the experiment, we found 
by accident that the Masson’s stained bone tissue could also emit red fluorescence under 
561 nm laser excitation of the confocal microscope (red image in Figure 4-9C). This allows 
for simultaneous viewing with the upconversion fluorescent image (green in Figure 4-9(B, 
C)) of the FA:10Yb3+/0.5Ho3+ particles under 980 nm NIR laser excitation on the same 
confocal microscope. The superposition of the two fluorescent images endows us with an 
alternative mode to show distinctly the material-tissue interrelation. It lets us to know the 
detailed distribution and their interrelation of implanted material and bone tissue. 
Especially, the image superposition can clearly distinguish the difference of region ‘a’ and 
‘c’ in Figure 4-9A. It could be seen from Figure 4-9 (B, C) that the bone tissue could bond 
with the FA:10Yb3+/0.5Ho3+ particles and grew into the interval space between these 
particles; in other words, the apatite particles have interspersed and integrated in the 
interpenetrating network of new bone. The black area in Figure 4-9C corresponded to the 




Figure 4-9 (A) light image of Masson’s stained new bone tissue by light microscope after 
6-month implantation; (B) the overlap image of the tissue light image and the upconversion 
green fluorescent image of implanted FA:10Yb3+/0.5Ho3+ particles; (C) the superposition 
of red fluorescent image of new bone tissue under 561 nm laser excitation and the green 
fluorescent image of FA:10Yb3+/0.5Ho3+ particles under 980 nm NIR laser excitation. 
 
By using both red and green fluorescence, we investigated bone growth with the 
implantation time. Figure 4-10 showed the superposition of red (new bone tissue) and green 
(FA:10Yb3+/0.5Ho3+ particles) fluorescent images on histological sections of samples 
harvested at 2, 4, and 6 months. The green upconversion fluorescence was excited at 980 
nm and collected at 500-550 nm, while the red luminescence was excited at 561 nm and 
collected at 570-695 nm. At 2 months, most of the implanted FA: 10Yb3+/0.5Ho3+ particles 
were still in agglomerated states and surrounded by newly formed bone tissue, leading to 
green bulk with surrounding red tissue, as shown by the white arrow in Figure 4-10A. At 
4 months, the particles started to spread out, and new bone tissue had formed in between 
particles (Figure 4-10B). At 6 months, the implanted FA:10Yb3+/0.5Ho3+ particles had fully 




Figure 4-10 Two-photon confocal microscopic images of FA:Yb3+/Ho3+ particles (green) 
and new bone tissue (red) for samples harvested at 2 (A), 4 (B), and 6 (C) months after 
implantation. 
 
It is difficult to clearly differentiate newly formed bone tissue from the implanted 
biomaterial by traditional Masson’s or H.E. staining. Our results show that the introduction 
of FA:Yb3+/Ho3+ particles with upconversion luminescence allowed for observation and 
tracking of the distribution of both the new bone tissue and the implanted material during 
the osteogenesis (Figure 4-9B and Figure 4-10). This could previously not be observed by 
traditional optical microscopy (such as region ‘c’ in Figure 4-9A). In addition, 
upconversion luminescence could label the implanted material and scaffold, avoiding 
interference from auto-fluorescence of tissues. It is known that apatite particles that possess 
the capacity of bonding to bone tissue have been incorporated into degradable polymer 
matrices such as PLGA and PCL, to construct composite scaffolds for bone regeneration. 
This study suggests that FA:Yb3+/Ho3+ particles with stable, bright, and long-lasting 
upconversion luminescence can be incorporated into these degradable polymers to track 
the scaffolds, the scaffold-tissue interface and respective distribution, and the degraded 
scaffold fragments in vivo. Thus, lanthanide Yb3+ and Ho3+ co-doped apatite materials and 





FA:Yb3+/Ho3+ and HA:Yb3+/Ho3+ upconversion particles with various dopant 
concentrations were successfully fabricated by hydrothermal synthesis and thermal 
activation. These particles can emit both green and red upconversion luminescence when 
excited by 980 nm near-infrared laser. The upconversion luminescence ascribes to the 
energy transfer from Yb3+ ions (sensitizers) to adjacent Ho3+ ions (activators), which emit 




5I8 transitions. We show for 
the first time that it is possible to simultaneously distinguish the implanted material from 
the newly formed bone tissue, and track their respective distribution and integration during 
osteogenesis in vivo by using the prepared Yb3+/Ho3+ co-doped apatite particles as a novel 
bioactive labeling agent. In vitro and in vivo experiments demonstrate that the 
upconversion particles have good biocompatibility, bone-bonding capacity, and superiority 
in fluorescent tracking. Both the materials and methods presented in this research pave a 




CHAPTER 5 CONCLUSION AND OUTLOOK 
In this thesis we design and prepare new fluorescent probes based on rare earth doped 
apatite nanoparticles with DC or UC fluorescence to track the differentiation and 
osteogenic processes of BMSCs and bony tissues, including selecting right doping matrix 
and dopants, evaluating the system and tracking the cells and implanted biomaterials. 
In chapter 2, Terbium (Tb) doped fluorapatite (FA:Tb) and hydroxyapatite (HA:Tb) 
crystals are hydrothermally synthesized. Their composition, crystal structure, fluorescent 
and biological properties are investigated. The Tb-doped crystals are in nanoscale and 
present a uniform slender morphology. The doping of Tb3+ ions can promote the 
preferential growth of apatite nanocrystals along the c-axis (002) direction, and cause the 
binding energy to increase for FA:Tb3+ crystals or decrease for HA:Tb3+ crystals. The FA 
crystal structure tends to combine more Tb3+ ions than HA crystal structure, and shows a 
stronger green fluorescence. Four Tb-doping lattice models along apatite hexagonal 
structure are proposed, revealing a necessity for coexistent substitution mechanism of 
(Ca7Tb2©)(PO4)6(OH)2, (Ca6Tb2Na2)(PO4)6(OH)2, (Ca9Tb)(PO4)6(OH)O, and 
(Ca8TbNa)(PO4)6(OH)2. Labelled BMSCs were shown to reproducibly exhibit osteogenic 
differentiation potential in real-time PCR and ELISA assays. Long-term in vivo cell-
tracking experiments confirmed the stability of dextran-coated Tb-FA nanorods. The Tb-
doped apatite nanocrystals exhibit bright fluorescence, good cytocompatibility and 
excellent cell imaging capacity, providing feasibility for imaging and tracking of cells with 
multilineage differentiation. 
In chapter 3, rare-earth Yb3+ and Ho3+ co-doped fluorapatite (FA:Yb3+/Ho3+) crystals 
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were prepared by hydrothermal synthesis, and their structure, upconversion property and 
cell behavior were investigated. The crystals with a size of 16 by 286 nm have a hexagonal 
crystal structure of classic FA and a Ca/Yb/Ho molar ratio of 100/16/2.1. Several 
reasonable Yb3+/Ho3+ embedding lattice models along the fluorine channel of FA crystal 
cell were proposed for the first time, such as models for (Ca7YbHo©)(PO4)6F2, or 
(Ca6YbHoNa2)(PO4)6F2. The activated FA:Yb
3+/Ho3+ crystals were found to exhibit 
distinct upconversion fluorescence. The 543 and 654 nm signals in emission spectrum 




5I8 transitions of holmium, via 
980 nm near-infrared excitation and energy transfer of ytterbium. After surface coating 
with hydrophilic dextran, the crystals displayed clear fluorescent cell imaging. We 
determined the chondrogenic differentiation potential of the labeled BMSCsGFP using real-
time RT-PCR analysis, histological assessment and immunohistochemistry. The continuous 
luminescence was detected after 12 weeks post transplantation from the FA: Yb3+/Ho3+ 
upconversion crystals, while the GFP signal was significantly decreased after this time. 
The prepared novel FA:Yb3+/Ho3+ upconversion fluorescent crystals have a good prospect 
for biomedical applications. 
In chapter 4, lanthanide Yb3+ and Ho3+ co-doped fluorapatite (FA:Yb3+/Ho3+) and 
hydroxyapatite (HA:Yb3+/Ho3+) nanoparticles with varying dopant concentrations were 
prepared by hydrothermal synthesis and thermal activation. Their upconversion emissions 
were investigated via fluorescence spectrometer. Histological sections of the harvested in 
vivo samples were treated with Masson’s staining and imaged by inverted fluorescence 
microscopy and laser confocal microscopy. The results showed that controllable green and 
red upconversion emissions could be generated under 980 nm near-infrared excitation; the 
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FA:Yb3+/Ho3+ nanoparticles resulted in a superior green luminescence, while 
HA:Yb3+/Ho3+ dominated in red emission. The difference in green and red emission 
behavior between FA:Yb3+/Ho3+ and HA:Yb3+/Ho3+ was dependent on their lattice 
structure and composition. Two possible lattice models were proposed by us for Yb3+/Ho3+ 
co-doped HA and FA along the hydroxyl channel and fluorine channel of the apatite crystal 
structure. The upconversion apatite nanoparticles were used for the first time to clearly 
distinguish the implanted material from bone tissue, showing their distribution and 
integration. The superposition of images endows us with a better mode to show distinctly 
the material-tissue interrelation. The overlap of stained bone tissue light image and apatite 
upconversion fluorescent image, and the superposition of their fluorescent images 
indicated that new bone tissue could grow into the interval space between the apatite 
particles and fully integrate with these particles. Without the upconversion fluorescent 
image, it is almost impossible to observe many details only from the light image of the 
stained histological section. The upconversion apatite particles and image superposition 
method provide a novel strategy for long-term discriminable fluorescence tracking of 
implanted materials or scaffolds. 
Although these rare-earth doped apatite nanoparticles have been prepared and 
investigated by us for cell imaging and biomaterial tracking, it is still a pioneering research. 
A lot of further works have to be done to expand its biomedical applications. For example, 
the uniform downconversion apatite nanocrystals should be suitable for study on their 
morphology change during in vitro cytophagy and in vivo degradation. The upconversion 
apatite nanoparticles should be used for real-time in vivo tracking. Moreover, we can coat 
the surface of these nanoapatites with different functional groups for different targeting 
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purpose. A problem for upconversion real-time in vivo tracking might be that the emitting 
distance of the upconversion fluorescence is still limited in the body, though the NIR 
excitation light can penetrate deeper in the tissues. At the moment, engineers have tried 
their best to overcome this shortcoming by developing higher sensitive CCD detector to 
receive the weak fluorescence from deeper tissues. In addition to the progress mentioned 
in the thesis, the long term in vivo effect of the rare-earth doped apatite nanoparticles also 





APPENDIX AN AMORPHOUS SILICA-COATED PCL 
ELECTROSPUN FIBERS WITH A CORE-SHEATH STRUCTURE 
FOR BIOACTIVE AND BIODEGRADABLE SCAFFOLDS 
 
This work was done during May, 2014 – May, 2015 at Atlanta under the guidance of 
Prof. Younan Xia, the Wallace H. Coulter Department of Biomedical Engineering, Georgia 
Institute of Technology and Emory University; and cooperated with Justin Lipner and Dr. 
Stavros Thomopoulos, Department of Biomedical Engineering, Washington University, St. 
Louis, USA. 
Introduction  
Bone has the capacity for regeneration and self-healing in response to small bony 
injury via continuous remodeling.[117, 118] However, skeletal reconstruction of large bone 
defects created by trauma, infection, tumor resection and skeletal abnormalities is beyond 
the normal potential for self-healing,[119] and presents a difficult challenge to cure 
effectively.[120] Usually porous scaffolds are required to assist the reconstruction of these 
irreversible tissue defects. In recent years, the concept of bone tissue engineering has 
gained great importance as a promising strategy for bone regeneration, of which scaffolds 
become one of the three crucial factors besides cells and growth factors.[121] Among 
metallic, ceramic and polymeric scaffolds, the polymeric matrix attracts more attention in 
mimicking the extracellular matrix (ECM), endowing biodegradability, and providing low 
modulus comparable to living tissues. A considerable number of natural and synthetic 
degradable polymers are currently used as scaffolds, involving collagen,[122] cellulose,[123] 
elastin,[124] silk fibroin,[125] poly(lactic-co-glycolic acid) (PLGA), and poly (ε-caprolactone) 
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(PCL) etc.,[126] in which PLGA and PCL play an active role in mechanical properties, 
biodegradability, and matrix shaping.[127, 128] 
The design of scaffold architecture using different fabrication techniques also plays 
an important role in determining scaffold properties. For polymer scaffolds, the usual 
fabrication methods include gas forming, freeze-drying, salt leaching and replica 
methods.[129, 130] Electrospinning is a notably simple and versatile technique to generate 
continuous fibers or fiber mat with controllable fiber diameter, mat porosity, and surface 
morphology,[128, 131] which can serve as an ideal candidate scaffold for tissue regeneration. 
To construct ECM-like scaffolds with large surface area and high porosity, both PLGA and 
PCL microfibers have been fabricated by electrospinning. PLGA copolymer is a kind of 
hydrophobic and brittle polyester with high mechanical strength. Although its degradation 
rate can be adjusted by the ratio of lactic acid to glycolic acid, the degradation of PLGA is 
still too fast or come too sudden to control, due to its amorphous structure and high 
hydrolysis rate.[132] The in vivo degradation by-products are lactic acid and glycolic acid, 
which often cause stimulation to cells and tissues, and result in aseptic inflammation.[133] 
PCL is a hydrophobic and semi-crystalline polyester with high mechanical strength and 
high toughness.[127, 132] The degradation products are H2O and CO2, which enable PCL 
polymer to have better biocompatibility. However, the in vivo degradation process of PCL 
matrix is usually much slower than that of PLGA matrix.[130] 
Ceramic or inorganic coatings on implants can provide surface bioactivity to bond 
with bone tissue.[134, 135] A polymer scaffold for bone repair or reconstruction is also 
required to possess surface bone-bonding bioactivity in addition to providing a porous 
structure for bone ingrowth. Hydroxyapatite (HA)[136] and silica-based bioglass[137] have 
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been used as surface bioactive coatings. Bone tissue can form a strong link with the HA 
surface or the Si-rich layer. It may be an ideal scaffold that owns a 3D meshy structure 
constructed with degradable microfibers and degradable surface bioactive coatings. With 
the progress of bone regeneration and reconstruction, the degradable fibers and coatings 
can be gradually absorbed by living body and finally substituted by newly formed bone 
tissue. An amorphous coating should degrade more quickly than a crystalline coating 
during bone reconstruction. 
Comparing PCL with PLGA, both the surface of pure PCL fibers and the surface of 
pure PLGA fibers are hydrophobic, lack of high affinity to cell adhesion and attachment, 
and short of the capacity for bonding with bone tissue. PCL and its degradation products 
show better biocompatibility, but the degradation of PCL matrix is relatively slow, and 
requires longer time than that of PLGA. The aim of this research is to form a nanoscale 
silica coating on the PCL microfiber scaffolds to provide a capacity for bonding with bone 
tissue, and to adjust the mechanical properties. The effect of coating time and round (cycle 
index) on the thickness of silica coating, and the effect of coating time on the toughness, 
yield strength and elastic modulus of the coated fiber scaffolds were investigated. The 
cytocompatibility of the scaffolds was also evaluated via culture with cells.  
Materials and methods 
Materials.  
Poly (ε-caprolactone) (PCL, Mw ≈ 70, 000-90, 000), hexafluoroisopropanol (HFP), 
ethanol, tetraethyl orthosilicate (TEOS), ammonium hydroxide (NH4OH), and 
dichloromethane (DCM) were obtained from Sigma-Aldrich, USA. All of the chemicals 
were used as received. 
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Fabrication of the PCL electrospun fibers and fiber mat.  
PCL was dissolved in HFP at a concentration of 10%. The solution was loaded in a 
syringe attached with a 22-gauge needle and electrospun onto a rotating mandrel collector 
at a speed of 2 m/s. The injection rate was 0.5 mL/h, the working distance was about 20 
cm, and a voltage of 18 KV was applied. The fiber mat (fiber scaffold) was formed and 
collected from rotating mandrel collector after continuous uniaxially aligned stacking of 
the PCL electrospun fibers (Figure A1). 
 
Figure A1 Appearance of the uniaxially aligned fiber mat (A) compared with the random 
oriented fiber mat (B). 
 
Silica coating on the PCL fiber scaffolds. 
The electrospun PCL fiber scaffold supported on a wire frame was firstly plasma 
treated (PE50, Unitronics, NV) for 2 min for both sides to make the fiber scaffold 
hydrophilic according to our previous work.[138] Then the fiber scaffold was soaked into 
the solvent mixture of water (5 mL) and ethanol (30 mL) followed by the addition of TEOS 
(0.05 mL) and ammonium hydroxide (1 mL). The resulting solution was stirred at 300 rpm 
at 21 °C for 4, 6, and 10 h, respectively. The product was washed with water three times 
and then freezing dried. The 4 h process was repeated for two and four rounds (cycle index) 
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to fabricate the 2x and 4x samples. 
Characterization.  
Scanning Electron Microscopy (SEM, Hitachi SU8230) was used to visualize the 
fibers and the coating morphologies. The samples were sputter coated with Au-Pd for 60 s, 
and an accelerating voltage of 2 kV was used. The energy dispersive spectroscopy (EDS) 
was also used for analyses of coating elements. Thickness of the coating was measured by 
a Transmission Electron Microscopy (TEM, Hitachi HT7700) with an accelerating voltage 
of 120 kV. Some TEM samples were prepared by dissolving the PCL core with DCM and 
then dispersed in ethanol. X-ray diffraction (XRD, X’ Pert PRO Alpha-1) was used to 
investigate the crystal structure of PCL matrix and the coating mineral phase after 
dissolving the PCL core, over a 2θ degree range of 10 to 60 degree using Cu Kα radiation 
(λ = 1.5406 Å). Fourier transform infrared spectra (FT-IR, Varian 640-IR) were conducted 
using KBr as the sample holder. The resolution in the spectrum collection was set at 1 cm-
1, and the scanning range was set from 4000 cm-1 to 400 cm-1. 
Mechanical testing of the fiber scaffolds.  
Samples coated for 0, 4, 6 and 10 h and 2x, 4x rounds were tested under tension to 
determine their mechanical properties. The fiber scaffold was cut into strips of about 14 x 
3 x 0.08 mm3 in size for uniaxial tensile mechanical testing (n = 5 per group). The scaffold 
thickness was measured using a laser micrometer (LK-081, Keyence), and the width was 
measured from calibrated digital images. The cross-sectional area was calculated as the 
width multiplied by the thickness. A texture-rich pattern of alizarin red dye was sprayed 
onto the test strip for optical deformation tracking. Mechanical testing was then performed 
under uniaxial tension at a strain rate of ∼0.5% per second using a materials testing system 
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(ElectoPuls, Instron). Testing was recorded by video at 1360 x 1024 resolution at 2.5 fps 
using a CCD camera (DP70, Olympus). The engineering stress was calculated as the load 
divided by the initial cross-sectional area, and the finite strain was determined from image 
data using custom Matlab (Mathworks, Natick MA) routines. The modulus was calculated 
as the slope of the linear region of the stress-strain curve. The toughness was calculated as 
the area under the stress-strain curve, reflecting the energy absorption of the material. 
Cell culture on the scaffolds.  
Mouse embryo-derived, fibroblastic cells (NIH/3T3; ATCC CRL-1658) were cultured 
in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, Grand Island, NY), 
supplemented with 10% fetal bovine serum (FBS, Invitrogen), and 1% antibiotics 
(containing penicillin and streptomycin, Invitrogen). The medium was changed every other 
day, and the cultures were incubated at 37 °C in a humidified atmosphere containing 5% 
CO2. 
Cell viability assay.  
The cell proliferation was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) assay (Invitrogen). MTT is a tetrazole that is 
metabolized and reduced to purple formazan in live cells. Coated PCL scaffolds (8 × 10 
mm2 area per piece, n = 3) were fixed onto microscope cover glass, and placed in wells of 
a 24-well plate (Corning). The samples were sterilized in 70% ethanol overnight, and then 
washed with phosphate buffer saline (PBS) three times. Cells were seeded in each well and 
cultured in 1 mL culture medium (DMEM). After culturing for 1, 2, and 3 days, 40 μL of 
MTT solution in PBS (5 mg/mL) was added to each well and incubated at 37 °C for 4 h. 
The scaffolds were then detached from the glass and transferred to a 96-well plate 
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(Corning), and 300 μL of DMSO was added to each well to completely dissolve formazan 
crystals throughout the scaffolds. The scaffolds were finally removed. Absorbance was 
measured at 570 nm using a spectrophotometer (Infinite F200 Pro, TECAN, Morrisville, 
NC). All final data were normalized to the actual area of each scaffold. 
Statistical analysis 
The data are presented in the form of mean ± standard deviation. Statistical 
comparisons were made using Student’s t-test and statistically significant was attained at p 
< 0.05. 
Results and Discussion 
In our hypothesis, both the coating time and the coating cycle may affect the thickness 
of the mineralized coating on scaffold fibers, which could further affect the mechanical 
properties and surface bioactivity. Figure A2 shows SEM images and TEM insets of the 
uniform nano-coating on PCL microfibers. The average diameter of the uniaxially aligned 
PCL microfibers is about 0.45 µm (Figure A2A). Figure A2B-D and upper right TEM insets 
exhibit the morphology and thickness of coatings formed in ethanol-TEOS solution for 4, 
6, and 10 h, respectively. The thickness rises rapidly from 28 nm (4h) to 40 nm (6h), then 
gradually to 50 nm at 10 h, and the coatings attach tightly on the surface of PCL microfibers 
without interface gap. It can be seen that the coating thickness can be controlled not only 
by adjusting the coating time but also by the cycle index. Figure A2E-F show that the 
thickness also grows with rounds (2x and 4x, 4 h per round), giving a value of about 60 nm 
and 90 nm, respectively. Both the coating time and cycle index are proportional to the 
thickness of the surface coating. And we find that the silica coating grows faster at first two 
rounds than extending time; the coating of two rounds (2x, 8 h in total) group is 10 nm 
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thicker than that of 10 h group (Figure A3), however the coating thickness at second two 
rounds (from 8 h to 16 h) increases only 30 nm, much slower than the first two rounds. It 
should be noted that the fiber diameter also shows a slight increase with the coating time 
(see TEM insets in Figure A2B-D), swelling of PCL fibers may occur in the ethanol-TEOS 
solution during the coating process.  
Figure A2 SEM images of PCL electrospun microfibers coated for (A) 0 h, (B) 4 h, (C) 6 
h, (D) 10 h, (E) 2 rounds (8 h), and (F) 4 rounds (16h). Insets are the corresponding TEM 





Figure A3 Dependence of the coating thickness on the coating time (A) and coating rounds 
(B). 
 
Plasma treatment plays a vital role in the formation of uniform mineralized coating 
via transferring the hydrophobic fiber surface to hydrophilic one with opened carboxylic 
groups.[138] Without plasma treatment, fine coating is hard to form (Figure A4A). We found 
that a uniform and close-grained coating could be obtained with proper plasma treatment 
time (2 min, Figure A4C). When the plasma treatment time is too short (30 S) or too long 
(10 min), uneven coatings are formed (Figure A4 (B, D)). It indicates that the plasma 
treatment on the surface of PCL fibers will affect the deposition of coating ions or groups 
on the fiber surface via changing the surface hydrophilicity and nucleation site. If the 
plasma treatment time is too short, only partially hydrophilic surface and small number of 
nucleation sites can be formed, leading to microsphere aggregation (Figure A4B); if the 
plasma time is too long, the fiber surface could be destroyed and cracked, resulting in a 




Figure A4 Mineralized coating on the PCL microfibers after plasma treatment for (A) 0, 
(B) 0.5, (C) 2, and (D) 10 min. 
 
To understand the composition and structure, XRD patterns, FTIR spectra, SEM 
image and EDS mapping were utilized for analysis of the PCL fibers and surface coatings. 
The XRD pattern in Figure A5A(a) illustrates that the PCL microfibers have a semi-
crystalline structure with characteristic peaks at 21.4° and 23.6°, corresponding to the 
orthorhombic planes (110 and 200) of PCL. Figure A5A(b) shows the pattern of silica 
coating with a diffusive peak at about 20-30°, which demonstrates a typical structure of 
amorphous hydrated silica. In Figure A5B(a) of PCL fibers, the peaks at 2945 cm-1, 2867 
cm-1, and at 1238 cm-1, 1171 cm-1 belong to the asymmetric and symmetric stretching 
vibration of -CH2 and -C-O-C, respectively. The absorption peak at 1731 cm
-1 is related to 
the carbonyl stretching. Figure A5B(b) displays three characteristic peaks of silica.23 The 
absorption peaks at 1097 cm-1 and 803 cm-1 correspond to the stretching vibration of Si-
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OH and Si-O, respectively. The peak at 470 cm-1 corresponds to bending vibration of the 
Si–O–Si bond. In addition, 3443 cm-1 ascribes to the O-H stretching vibration of physically 
adsorbed water, 1632 cm-1 is bending vibration absorption of physically adsorbed water. 
An SEM image of silica coating sheath is shown in Figure A5C after dissolving the PCL 
fiber core by DCM. The coating exhibits continuous and uniform tubular structure with a 
certain wall thickness. EDS analysis on the coating wall in Figure A5D shows the presence 
of Si and O elements. The results indicate that the mineralized coating is composed of 
amorphous silica. 
 
Figure A5 XRD patterns (A) of the PCL microfibers (a) and silica coating (b), FT-IR spectra 
(B) of the PCL microfibers (a) and silica coating (b), SEM image (C) of silica coating 
sheath after dissolving PCL fiber core, and EDS mapping of coating elements. 
 
Figure A6 gives a schematic diagram to illustrate the formation mechanism of silica 
coating. After plasma treatment, the surface carboxyl (COO-) groups of PCL fibers react 
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with the hydrolyzate (Si-OH) groups of TOES to form C-O-Si bonds, then the 
condensations of neighbor Si-OH groups produce abundant Si-O-Si bonds, on which 
nucleation comes up, accompanied by continuous growth of silica coating. 
 
Figure A6 Schematic diagram showing the mechanism of the formation of silica coating. 
 
As we know, both the HA coating and the silica coating have good cell affinity and a 
capacity for bonding with bone tissue.[135-137] Comparing with the HA coating on 
microfibers,[138] the silica coating (Figure A2) looks more uniform and close-grained, 
especially it shows an amorphous structure that could be helpful for faster degradation and 
absorption with new tissue formation over time. When mineralized coating is formed on 
polymer fibers, usually the elastic modulus of the coated fibers or fiber scaffolds will 
increase with the coating formation. However, a reverse phenomenon appears in this 
experiment. As shown in Figure A7A, the silica-coated PCL fiber scaffolds with a coating 
time 4, 6, and 10 h have a smaller modulus than the pure PCL fiber scaffold (0 h). Among 
the three coated fiber scaffolds, the 6 h sample shows a highest value of modulus. For the 
toughness, all the three coated scaffolds have a bigger value of toughness than that of pure 
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PCL scaffold. The scaffold coated for 6 h holds the highest toughness (Figure A7B) and 
yield stress (i.e. strength, in Figure A7C). This reveals that the 6 h silica-coated PCL fiber 
scaffold may possess superior interface quality between the coating and PCL fibers. 
 
Figure A7 Young’s modulus, fracture toughness and yield stress of PCL fiber scaffolds 
before and after silica coating for different time. 
 
The reduction of modulus after coating should be closely related to the swelling of 
PCL fibers in the ethanol-TEOS solution. It has been reported that the ethanol solution 
could cause swelling of the polyester fiber scaffold and largely decrease the fiber 
modulus.[139] Also, ethanol has sometimes been used for the swelling test of PCL matrix. 
From the TEM insets of Figure A2(B-D), the small increase in fiber diameter with the 
coating time could demonstrate the swelling occurrence of the PCL fiber scaffolds in the 
ethanol-TEOS solution during the coating process, and even after freeze-drying, the 
swelling of PCL matrix cannot be completely reversed. This should be the main reason for 
the modulus reduction of the coated PCL fiber scaffolds. Swelling or structure relaxation 
of PCL matrix happens chiefly in the non-crystalline region, because the crystallinity of 
the crystalline region does not show significant difference (Figure A8A). As we know, the 
degradation of PCL matrix mainly starts from its amorphous region. The swelling or chain 
relaxation of PCL amorphous region could facilitate the water penetration of body fluid 
into the PCL matrix, then speeding up the hydrolysis of ester linkage and the in vivo 
degradability of PCL matrix. 
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After coating for 4 h, the modulus reduction is mainly caused by the ethanol induced 
net swelling and chain relaxation of PCL matrix, although the silica coating can increase 
the modulus to some extent. At 6 hours, the effect of rapidly increased coating thickness 
on the increase of modulus exceeds the effect of gradual swelling of PCL fibers on the 
modulus reduction, resulting synthetically in the rise of the modulus. For 10 hours of 
coating, the subsequent incrassation of coating may lead to increased interfacial stress 
between the silica coating and PCL fibers, thus reducing again the modulus of the coated 
fiber scaffold. When the coating becomes too thick, the interfacial stress between coating 
and fiber, and internal stress of coating itself will even cause interface debonding and 
coating cracking (Figure A8B). Therefore, control of the coating time or coating thickness 
is crucial for obtaining high quality coating interface. 
 
Figure A8 XRD patterns (A) of the pure PCL fibers and the silica-coated PCL fibers, and 
TEM image (B) showing the loosened interface between PCL fiber and thick silica coating. 
 
MTT assay was conducted to study the response of cells to the PCL fiber scaffolds 
with different silica coating thickness. Figure A9 shows that the cell proliferation rate of 
different coating thickness groups increases markedly and continuously with the culture 
time. And all experimental groups show a higher proliferation rate than the pure PCL 
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control (P <0.05). On Day 3, they still exhibit a normal growth status. It indicates that the 
silica coating affords superior cellular affinity, and the silica-coated PCL fiber scaffolds 
have good cytocompatibility, suitable for further in vivo investigation. 
 
Figure A9 MTT assay for cell proliferation cultured with PCL fiber scaffolds of different 
thickness for 1, 2, and 3 days, error bars represent mean ± SD from triplicate experiments, 
p < 0.05 (* vs. control, # vs. 4 h, ^ vs. 6 h). 
 
It is important to optimize a scaffold by adjusting each component. A bone scaffold 
must have good biocompatibility and must be osteoconductive. Both the PCL matrix and 
the silica coating are biologically safe for living body, and the silica coating provides an 
osteoconductive capacity to bond with bone tissue. Biodegradability is another crucial 
factor for scaffolds.[140] The scaffold should serve to provide a temporary structure, which 
subsequently degrades in tandem with new tissue formation over time.[141] PCL polymer is 
a biodegradable material with relatively slow degradation rate.[130] Reduction in size and 
modulus would be an effective way to accelerate its degradability. The use of ultrafine 
electrospun PCL fibers and the reduced elastic modulus in this experiment would be 
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beneficial to an achievement of a faster biodegradation. The use of amorphous silica 
coating is also helpful for more rapid in vivo degradation comparing with the crystalline 
coatings. In addition, when used for bonding to bone at the tendon-to-bone insertion site, 
the aligned ECM-like fiber structure, and the improved toughness and strength of the silica-
coated PCL fibrous scaffold have also an advantage to allow effective energy transmission 
along the long axis of adjacent muscle loading, except the uniaxially aligned electrospun 
PCL microfibers can mimic the highly anisotropic structure of a tendon tissue. 
Consequently, the core-sheath PCL fiber scaffold with nanoscale amorphous silica coating 
will present a promising prospect for future biomedical applications. 
Conclusion 
In this experiment, nanoscale amorphous silica coating with a uniform and close-
grained structure has been successfully formed on the ultrafine PCL electrospun fibers via 
a mixed solution of ethanol and tetraethyl orthosilicate. The coating technique leads to an 
increase in fracture toughness and yield strength, and a reduction in the elastic modulus of 
the coated fibrous scaffolds. Swelling of PCL matrix by ethanol should be responsible for 
the modulus reduction. The ultrafine fibers and the reduced scaffold modulus would be 
beneficial to an achievement of a faster biodegradation regarding to the slow in vivo 
degradation rate of PCL matrix. The silica coating can provide a capacity for the fiber 
scaffolds to bond with bone tissue. In summary, we have demonstrated a simple and 
versatile method to produce amorphous silica coating on PCL microfibers, and to adjust 
the nano-coating thickness and mechanical properties. The in vivo investigation of this 
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